Financial release and supplemental presentation accessible online
, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that financial results for its fourth quarter fiscal year 2026, which ended March 28, 2026, are available on the Company's Investor Relations website at www.haemonetics.com.
The Company will host a conference call and webcast with investors and analysts to discuss and answer questions about the results at 8:00 a.m. ET on May 7, 2026.
Conference Call and Webcast Information:
Registration: Click here to register. Upon registration, participants will receive dial-in details and a personalized PIN. While not required, joining 10 minutes prior to the event start time is recommended. Live webcast: Access here or through the Investor Relations section of the Haemonetics website. A replay of the conference call and webcast will be available beginning at 11:00 a.m. ET on May 7, 2026 and will remain accessible for one year via the webcast link above.
Earnings Materials:
Haemonetics has also posted the following materials on its Investor Relations website, which will be referenced during the conference call and webcast:
Fourth Quarter Fiscal 2026 Earnings Release Fourth Quarter Fiscal 2026 Supplemental Earnings Presentation ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Haemonetics (HAE) came out with quarterly earnings of $1.29 per share, beating the Zacks Consensus Estimate of $1.28 per share. This compares to earnings of $1.24 per share a year ago.
Although the revenue and EPS for Haemonetics (HAE) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Matson was the top performer as container shipping rates strengthened amid supply chain disruptions and management executed on operational efficiency initiatives. Revolve Group sold off as the online fashion retailer faced softer consumer demand and lower discretionary spending. We added to Haemonetics Corporation following recent share price volatility.
MarketBeat Instant News Alerts Trending News All MarketBeat Instant News Alerts Sort By
Time Frame
Alert Type
Keywords
Page 1 of 324
Get 30 Days of MarketBeat All Access for Free
Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools.
Start Your 30-Day Trial
Sign in to your free account to enjoy these benefits
In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer.
Key Takeaways HAE topped Q4 adjusted EPS and revenue estimates; shares gained 1.4% after results. Haemonetics' gross margin slid to 57.2% as COGS rose 7.7%, swinging to a $23.0M operating loss. HAE guided FY27 revenue growth of 4-7% and said adjusted EPS should rise roughly in line with revenues. Haemonetics Corporation (HAE - Free Report) delivered fourth-quarter fiscal 2026 adjusted earnings of $1.29 per share, up 4.0% year over year. The figure beat the Zacks Consensus Estimate by 1.0%.
On a GAAP basis, loss per share was 44 cents compared to earnings of of $1.17 per share in the prior-year quarter.
HAE posted adjusted earnings per share of $4.96 for fiscal 2026, up from $4.57 in fiscal 2025.
HAE’s RevenuesRevenues rose 4.8% from the year-ago period’s level to $346.35 million, topping the Zacks Consensus Estimate by 2.4%.
For fiscal 2026, the company generated total revenues of $1.33 billion, down 2.0% from the prior-year figure.
Strength across the company’s core platforms stood out, with organic revenue growth of 4.5% and organic growth excluding CSL impacts of 8.6%, helping offset continued softness in interventional technologies.
Following the earnings announcement, HAE’s shares rose 1.4% last Friday.
HAE’s Q4 Segmental Details At Plasma, revenues totaled $130.3 million, up 2.8% year over year (up 1.8% on an organic basis). Organic growth, excluding CSL impacts, was 12.7%, reflecting continued momentum in the franchise.
Revenues at Blood Center increased 0.7% to $56.4 million (up 5.5% on an organic basis). The segment’s organic performance reflected the benefit of portfolio-adjusted growth.
Hospital revenues rose 8.0% to $159.6 million (up 6.5% organically).
HAE’s Margin AnalysisIn the fourth quarter of fiscal 2026, gross profit increased 2.7% to $198.2 million. Gross margin contracted 120 basis points (bps) year over year to 57.2% as cost of goods sold rose 7.7% to $148.1 million.
Selling, general and administrative expenses increased 5.6% to $121.8 million, while research and development expenses declined 9.2% to $14.4 million. Total operating expenses jumped 81.8% to $221.2 million, driving an operating loss of $23.0 million compared to operating income of $71.3 million in the prior-year quarter.
Haemonetics Financial Position Haemonetics ended fiscal 2026 with $245.4 million in cash and cash equivalents compared to $306.8 million at the end of fiscal 2025.
Cumulative net cash flow at the end of fiscal fourth-quarter 2026 was $293.2 million compared with $181.7 million a year ago.
Haemonetics Corporation Price, Consensus and EPS SurpriseHAE’s Fiscal 2027 Guidance Management expects reported revenue growth of 4-7%, including an estimated 53rd-week impact of roughly 2% and a currency impact of 0-1%. Organic revenue growth is projected at 3-6%, with approximately mid-single-digit growth expected in both Plasma and Hospital and a mid-single-digit decline anticipated in Blood Center. The Zacks Consensus Estimate for fiscal 2027 revenues is pegged at $1.41 billion.
Adjusted earnings per diluted share are expected to grow in line with revenues. The Zacks Consensus Estimate is pegged at $5.30.
Our TakeHaemonetics ended the fiscal fourth quarter with better-than-expected results, wherein both earnings and revenues surpassed estimates.
Strong fiscal fourth-quarter performance was largely driven by core platforms, with outperformance in Plasma and Blood Management Technologies businesses. The company completed the four-year long-range plan, having built a more diversified, sustainable and durable business. With a strengthened competitive position and focus on disciplined execution, it has momentum for fiscal 2027 and beyond.
The contraction of gross margin in the quarter does not bode well.
HAE’s Zacks Rank & Key Picks Haemonetics currently carries a Zacks Rank #3 (Hold).
Some better-ranked stocks from the broader medical space are Alcon (ALC - Free Report) , Intuitive Surgical (ISRG - Free Report) and Phibro Animal Health (PAHC - Free Report) .
Alcon, currently carrying a Zacks Rank #2 (Buy), reported a fourth-quarter 2025 EPS of 78 cents, which missed the Zacks Consensus Estimate by 0.8%. Revenues of $2.70 billion missed the Zacks Consensus Estimate by 0.2%. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
ALC has an earnings yield of 2.5% compared to the industry’s negative 1.6% yield. The company’s earnings surpassed estimates in two of the trailing four quarters and missed in the other two, the average surprise being 1.11%.
Intuitive Surgical, carrying a Zacks Rank #2 at present, posted a first-quarter 2026 adjusted EPS of $2.50, which exceeded the Zacks Consensus Estimate by 20.2%. Revenues of $2.77 billion topped the Zacks Consensus Estimate by 6.2%.
ISRG has an earnings yield of 2.1% in contrast to the industry’s negative yield of 0.9%. The company’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 16.82%.
Phibro Animal Health, carrying a Zacks Rank #2 at present, posted a second-quarter fiscal 2026 adjusted EPS of 87 cents, which outpaced the Zacks Consensus Estimate by 27.01%. Revenues of $373.9 million outperformed the Zacks Consensus Estimate by 4.72%.
PAHC has an estimated long-term earnings growth rate of 21.5% compared with the industry’s 12.1% growth. The company’s earnings outpaced estimates in each of the trailing four quarters, the average surprise being 20.15%.
Investors in Haemonetics Corporation (HAE - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the June 18, 2026 $40.00 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell-off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for Haemonetics, but what is the fundamental picture for the company? Currently, Haemonetics is a Zacks Rank #3 (Hold) in the Medical - Products industry that ranks in the Bottom 39% of our Zacks Industry Rank. Over the last 60 days, no analyst has increased his earnings estimate for the current quarter, while two have dropped their estimates. The net effect has taken our Zacks Consensus Estimate for the current quarter from $1.19 per shareto $1.10 in that period.
Given the way analysts feel about Haemonetics right now, this huge implied volatility could mean there’s a trade developing. Oftentimes, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
On May 21, 2026, Haemonetics Corp (HAE) shares rose 4.0%, bringing the current price to $61.94. The stock has fluctuated significantly over the past year, with
May 27, 2026 07:00 ET | Source: BioCryst Pharmaceuticals, Inc.
RESEARCH TRIANGLE PARK, N.C., May 27, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the company will present seven abstracts from its hereditary angioedema (HAE) portfolio at the Annual Meeting of the European Academy of Allergy and Clinical Immunology (EAACI) taking place in Istanbul, Turkey, from June 12-15, 2026.
Data include six abstracts featuring new clinical trial and real-world outcomes with ORLADEYO® (berotralstat), the first and only targeted oral prophylactic therapy for patients with HAE aged 2 and older, and one abstract featuring clinical trial outcomes with navenibart, a long-acting, monoclonal antibody plasma kallikrein inhibitor being investigated for prophylaxis to prevent attacks of HAE.
BioCryst poster presentations include:
Real-World Patient Characterization, Prior Long-Term Prophylactic Prescribing Patterns, and Treatment Outcomes for Adults on Berotralstat with Hereditary Angioedema in Japan; poster D1.407; Friday, June 12, 12:00–13:00 p.m. (TRT)
Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilising Professional Care in Paediatric Patients Aged 2 to <12 years: APeX-P Results Through 48 Weeks; poster D2.498; Saturday, June 13, 12:00–13:00 p.m. (TRT)
Reductions in Hereditary Angioedema Attacks among Patients with C1 Esterase Inhibitor Deficiency Who Switched from Another Long-Term Prophylaxis to Berotralstat; poster D2.360; Saturday, June 13, 12:00–13:00 p.m. (TRT)
Hereditary Angioedema Attack Rates among Patients with Normal C1 Esterase Inhibitor Before and After Switching from Another Long-Term Prophylaxis to Berotralstat; poster D2.357; Saturday, June 13, 12:00–13:00 p.m. (TRT)
Reductions in Healthcare Resource Utilization in Adolescents with Hereditary Angioedema on Berotralstat; poster D2.361; Saturday, June 13, 12:00–13:00 p.m. (TRT)Clinical Outcomes with Navenibart According to Baseline Attack Rate, Body Mass Index, and Age: Results of the ALPHA-STAR Trial; poster D3.438; Sunday, June 14, 12:15–13:15 p.m. (TRT)
Hereditary Angioedema Attack Frequency and Severity According to Individuals Taking Berotralstat for Long-Term Prophylaxis; poster D3.324; Sunday, June 14, 12:15–13:15 p.m. (TRT)
Visit www.ORLADEYO.com for more information.
About ORLADEYO® (berotralstat)
ORLADEYO® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 2 years and older. One dose of ORLADEYO per day works to prevent HAE attacks by decreasing the activity of plasma kallikrein.
About navenibart
Navenibart is an investigational YTE-modified monoclonal antibody inhibitor of plasma kallikrein, an established and safe mechanism, currently being evaluated in clinical trials for long-term prevention of HAE attacks with potential best-in-class dosing every 3 or 6 months.
U.S. Indication and Important Safety Information
INDICATION
ORLADEYO® (berotralstat) is a plasma kallikrein inhibitor indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 2 years and older.
Limitations of use
The safety and effectiveness of ORLADEYO for the treatment of acute HAE attacks have not been established. ORLADEYO should not be used for the treatment of acute HAE attacks. Additional doses or doses of ORLADEYO higher than the prescribed once-daily dose are not recommended due to the potential for QTc interval prolongation.
IMPORTANT SAFETY INFORMATION
An increase in QTc interval was observed in adults at dosages higher than 150 mg once daily and was concentration dependent.
The most common adverse reactions (≥10%) in patients receiving ORLADEYO were abdominal pain, vomiting, diarrhea, back pain, and gastroesophageal reflux disease.
In adult and pediatric patients aged 12 years and older with moderate or severe hepatic impairment (Child-Pugh B or C), the recommended dosage of ORLADEYO capsules is 110 mg once daily with food. In pediatric patients aged 2 to <12 years with moderate or severe hepatic impairment (Child-Pugh B or C), avoid use of ORLADEYO.
Berotralstat is a substrate of P-glycoprotein (P-gp) and breast cancer resistance protein. P-gp inducers may decrease berotralstat plasma concentration, leading to reduced efficacy of ORLADEYO. Avoid concomitant use of P-gp inducers with ORLADEYO.
ORLADEYO at a dose of 150 mg is a moderate inhibitor of CYP2D6 and CYP3A4. Concomitant use of ORLADEYO with CYP2D6 or CYP3A4 substrates can increase exposure of the CYP2D6 or CYP3A4 substrates and may increase the risk of adverse reactions associated with the substrates. If ORLADEYO is concomitantly used with CYP2D6 or CYP3A4 substrates where minimal increases in the concentration of the substrates may lead to serious adverse reactions, closely monitor or modify the dosage of the CYP2D6 or CYP3A4 substrate.
The safety and effectiveness of ORLADEYO in pediatric patients <2 years of age have not been established.
There are insufficient data available to inform drug-related risks with ORLADEYO use in pregnancy. There are no data on the presence of berotralstat in human milk, its effects on the breastfed infant, or its effects on milk production.
To report SUSPECTED ADVERSE REACTIONS, contact BioCryst Pharmaceuticals, Inc. at 1-833-633-2279 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
About BioCryst Pharmaceuticals
BioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of people living with these conditions. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of potential first-in-class or best-in-class oral small-molecule and injectable protein therapeutics for a range of rare diseases. For more information, please visit www.biocryst.com or follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding new clinical trial and real-world outcomes with respect to BioCryst’s HAE portfolio and the potential dosing profile and competitive positioning of navenibart. These statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: risks related to the development and interpretation of clinical and real-world data; BioCryst’s ability to successfully progress its development plans for navenibart; the outcome of preclinical testing and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results; ongoing and future clinical development of product candidates, including navenibart, may take longer than expected and may not have positive results; the FDA or other applicable regulatory agencies may require additional studies beyond the studies planned for navenibart, may not provide regulatory clearances which may result in delay of planned clinical trials, may not review regulatory filings on our expected timeline, may impose certain restrictions, warnings, or other requirements, may impose a clinical hold, or may withhold, delay or withdraw market approval, may ultimately determine that there are deficiencies in the development program or execution thereof, may require additional information or studies, may disagree with our safety and efficacy conclusions, or may impose certain restrictions, warnings, or other requirements; and risks related to the expected dosing or best-in-class profile of navenibart. This list is not exclusive. To see a more comprehensive set of risks, please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, which identify important factors that could cause actual results to differ materially from those contained in BioCryst’s forward-looking statements.
[url="]KalVista Pharmaceuticals[/url], Inc. (Nasdaq: KALV) today announced new data highlighting the burden of injectable on-demand treatment in children aged
, /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE) announced that Chris Simon, President and CEO, will participate in a fireside chat with investors at the Goldman Sachs 47th Annual Global Healthcare Conference on Monday, June 8, 2026 at 4:00 p.m. ET.
The public may access a live webcast of the fireside chat at Haemonetics' Investor Relations website or at the following link:
https://event.webcasts.com/starthere.jsp?ei=1766065&tp_key=0b16b4b62d&tp_special=8
A replay of the recorded webcast will become accessible 12 hours after the event and will be available for 90 days on Haemonetics' Investor Relations website.
ABOUT HAEMONETICS
Haemonetics is a global medical technology company dedicated to improving the quality, effectiveness and efficiency of health care. Our innovative solutions addressing critical medical needs include a suite of hospital technologies designed to advance standards of care and help enhance outcomes for patients; end-to-end plasma collection technologies to optimize operations for plasma centers; and products to enable blood centers to collect in-demand blood components. To learn more about Haemonetics, visit www.haemonetics.com.
Investor Contacts:
Olga Guyette, Vice President-Investor Relations & Treasury
BOSTON, June 5, 2026 /PRNewswire/ -- Haemonetics Corporation (NYSE: HAE), a global medical technology company focused on delivering innovative solutions designed to improve patient outcomes, today announced an update to its reportable segment structure to better align external financial reporting with how the Company manages its business and allocates resources. Under the new structure, Haemonetics will transition from three reportable segments to two.
ZUG, Switzerland, June 11, 2026 (GLOBE NEWSWIRE) -- Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced the annual general meeting of shareholders will take place on Friday, June 26, 2026, at 16:00 CEST (10:00 a.m. EDT).
All relevant documents and information relating to the annual general meeting, including the notice and agenda for the annual general meeting, are or will be made available in the “Investors” section of Pharvaris’ website under “Events & Presentations”. The documents will also be made available on the SEC’s website at www.sec.gov. Shareholders who wish to attend the meeting should register as described in the notice and agenda for the annual general meeting.
About Pharvaris
Pharvaris is a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs in bradykinin-mediated conditions, including all types of bradykinin-mediated angioedema. Pharvaris’ aspiration is to offer therapies with injectable-like efficacy™, a well-tolerated profile, and the convenience of oral administration to prevent and treat bradykinin-mediated angioedema attacks. By delivering on this aspiration, Pharvaris aims to provide a new standard of care in bradykinin-mediated angioedema. Pharvaris is preparing marketing authorization applications for deucrictibant immediate-release capsule as an on-demand treatment of HAE attacks, and a global pivotal Phase 3 study of deucrictibant extended-release tablet for the prevention of HAE attacks (CHAPTER-3) is ongoing with topline data anticipated in the third quarter of 2026. In addition, CREAATE is an ongoing Phase 3 study of deucrictibant for the prophylactic and on-demand treatment of AAE-C1INH attacks. For more information, visit https://pharvaris.com/.
— Growing body of ORLADEYO® clinical data and real-world evidence demonstrates consistent reductions in HAE attack burden and healthcare utilization across diverse patient populations
— New post hoc analysis of Phase 1b/2 ALPHA-STAR study of investigational navenibart demonstrates consistent reductions in HAE attack rates across patient subgroups, supporting ongoing Phase 3 evaluation as a potential long-acting therapeutic option for the broad HAE population
RESEARCH TRIANGLE PARK, N.C., June 12, 2026 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced new clinical data and real-world evidence for ORLADEYO® (berotralstat), the first and only targeted oral prophylactic therapy for patients with hereditary angioedema (HAE) aged 2 and older, in addition to new data from the Phase 1b/2 multicenter, dose-ranging, open-label ALPHA-STAR study of navenibart, an investigational, long-acting, monoclonal antibody plasma kallikrein inhibitor for prophylaxis to prevent attacks of HAE. These data will be featured across multiple poster presentations during the European Academy of Allergy and Clinical Immunology (EAACI) Annual Meeting in Istanbul, Turkey, from June 12-15.
“Together, these data reinforce the strength of our HAE portfolio, demonstrating consistent real-world impact for children and adults living with HAE today, while advancing next-generation treatment approaches to further improve outcomes, address ongoing clinical unmet need, and align with patient treatment preferences,” said Sandeep Menon, Chief Research and Development Officer of BioCryst.
New HAE Portfolio Clinical Data
Updated analysis of 48-week data from the ongoing APeX-P study, the largest trial of long-term prophylaxis (LTP) in pediatric patients with HAE, evaluating once-daily ORLADEYO in HAE patients aged 2 to <12 years will be featured in a poster presentation (Poster D2.498).
Analysis of 48-week trial data showed that treatment with ORLADEYO was associated with early and sustained reductions in rate and number of HAE attacks requiring on-demand treatment and professional care, with results as follows:
The median (range) adjusted HAE attack rate requiring on-demand treatment decreased from 0.691 attacks/month (0-5.03) during the 12-week standard of care (SOC) period to 0.169 attacks/month (0-1.75) during the 48-week ORLADEYO treatment period.The number of HAE attacks requiring professional care decreased from 22 during the 12-week SOC period to 3 over 12 weeks of ORLADEYO treatment; this was sustained throughout the treatment period, with a trended decrease in level of professional care required from emergency department or urgent care treatment to physicians’ office, and further reduction to 0 attacks during Week 37-48.No significant safety concerns were identified over the 48-week treatment period.
Additionally, a new post hoc analysis of the Phase 1b/2 ALPHA-STAR study of navenibart evaluating clinical outcomes across patient subgroups defined by baseline attack rate, body mass index (BMI), and age will be featured as a poster presentation (Poster D3.438).
The analysis demonstrated that investigational navenibart consistently reduced HAE attacks, with results as follows:
Reductions in overall HAE attack rate were observed across subgroups defined by baseline attack rate, BMI, and age.Following treatment, reductions in clinically relevant HAE outcomes were observed across analyzed subgroups, including reductions in moderate or severe attacks, and in baseline attack rate subgroup analyses, and reduced on-demand medication use. Reductions in the number of moderate or severe attacks were also observed with treatment across all BMI subgroups. Navenibart was previously shown to be well tolerated with no severe or serious treatment-emergent adverse events (TEAEs) reported and few injection site reactions. The most common TEAEs were headache, nasopharyngitis, and urinary tract infection. Together with the primary findings from Phase 1b/2 ALPHA-STAR, this analysis supports the ongoing Phase 3 evaluation of navenibart in the ALPHA-ORBIT trial as a potential long-acting therapeutic option for the broad HAE population.
Real-World Impact of ORLADEYO
Through a comprehensive real-world evidence (RWE) generation program, BioCryst continues its commitment to generating meaningful, practice-informing research to demonstrate the value of long-term prophylaxis with ORLADEYO in routine clinical practice across the diverse HAE patient community. In addition to clinical data generated in clinical trials, RWE across multiple studies demonstrated ORLADEYO’s ability to achieve sustained reductions in HAE burden. Benefits were observed in adolescent and adult patients, including those switching to ORLADEYO from other LTP therapies, and translated into fewer HAE attacks, reduced healthcare resource utilization, and high patient satisfaction.
This RWE will be presented in the following posters:
Real-World Patient Characterization, Prior Long-Term Prophylactic Prescribing Patterns, and Treatment Outcomes for Adults on Berotralstat with Hereditary Angioedema in Japan; poster D1.407; Friday, June 12, 12:00–13:00 p.m. (TRT)Reductions in Hereditary Angioedema Attacks among Patients with C1 Esterase Inhibitor Deficiency Who Switched from Another Long-Term Prophylaxis to Berotralstat; poster D2. 360; Saturday, June 13, 12:00–13:00 p.m. (TRT)Hereditary Angioedema Attack Rates among Patients with Normal C1 Esterase Inhibitor Before and After Switching from Another Long-Term Prophylaxis to Berotralstat; poster D2. 357; Saturday, June 13, 12:00–13:00 p.m. (TRT)Reductions in Healthcare Resource Utilization in Adolescents with Hereditary Angioedema on Berotralstat; poster D2.361; Saturday, June 13, 12:00–13:00 p.m. (TRT)Hereditary Angioedema Attack Frequency and Severity According to Individuals Taking Berotralstat for Long-Term Prophylaxis; poster D3.324; Sunday, June 14, 12:15–13:15 p.m. (TRT)
Visit www.ORLADEYO.com for more information.
About APeX-P
APeX-P is an ongoing, open-label study evaluating the pharmacokinetics, safety, and efficacy of ORLADEYO in patients aged 2 to <12 years with HAE due to C1-inhibitor deficiency. Before ORLADEYO initiation, patients received SOC for 12 weeks. The rates of HAE attacks requiring on-demand treatment and number of attacks requiring professional care were compared between 12 weeks of SOC and 48 weeks of ORLADEYO treatment. Participants (n=29) were placed in one of four cohorts by body weight at baseline.
About ALPHA-STAR
ALPHA-STAR is a Phase 1b/2, multicenter, dose-ranging, proof-of-concept, open-label trial that assessed the safety and clinical activity of single- and multiple-dose navenibart in adults aged 18 years and older with HAE due to C1-inhibitor deficiency. Eligible participants were those who experienced at least two HAE attacks during the 8-week trial run-in period. Participants (n=29) were placed in three navenibart dose cohorts and were pooled for the purpose of this post hoc analysis. Post hoc outcomes included the overall change from baseline in monthly HAE attack rate, the rate of attacks treated with on-demand medication, and the rate of moderate or severe attacks. Outcome measures were assessed for 6 months after the last dose. Due to small sample size and short-term study design, these data may not fully represent the broader population of patients with HAE.
About ORLADEYO® (berotralstat)
ORLADEYO® (berotralstat) is the first and only oral therapy designed specifically to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 2 years and older. One dose of ORLADEYO per day works to prevent HAE attacks by decreasing the activity of plasma kallikrein.
About navenibart
Navenibart is an investigational YTE-modified monoclonal antibody inhibitor of plasma kallikrein, an established and safe mechanism, currently being evaluated in clinical trials for long-term prevention of HAE attacks with potential best-in-class dosing every 3 or 6 months.
U.S. Indication and Important Safety Information
INDICATION
ORLADEYO® (berotralstat) is a plasma kallikrein inhibitor indicated for prophylaxis to prevent attacks of hereditary angioedema (HAE) in adults and pediatric patients 2 years and older.
Limitations of use
The safety and effectiveness of ORLADEYO for the treatment of acute HAE attacks have not been established. ORLADEYO should not be used for the treatment of acute HAE attacks. Additional doses or doses of ORLADEYO higher than the prescribed once-daily dose are not recommended due to the potential for QTc interval prolongation.
IMPORTANT SAFETY INFORMATION
An increase in QTc interval was observed in adults at dosages higher than 150 mg once daily and was concentration dependent.
The most common adverse reactions (≥10%) in patients receiving ORLADEYO were abdominal pain, vomiting, diarrhea, back pain, and gastroesophageal reflux disease.
In adult and pediatric patients aged 12 years and older with moderate or severe hepatic impairment (Child-Pugh B or C), the recommended dosage of ORLADEYO capsules is 110 mg once daily with food. In pediatric patients aged 2 to <12 years with moderate or severe hepatic impairment (Child-Pugh B or C), avoid use of ORLADEYO.
Berotralstat is a substrate of P-glycoprotein (P-gp) and breast cancer resistance protein. P-gp inducers may decrease berotralstat plasma concentration, leading to reduced efficacy of ORLADEYO. Avoid concomitant use of P-gp inducers with ORLADEYO.
ORLADEYO at a dose of 150 mg is a moderate inhibitor of CYP2D6 and CYP3A4. Concomitant use of ORLADEYO with CYP2D6 or CYP3A4 substrates can increase exposure of the CYP2D6 or CYP3A4 substrates and may increase the risk of adverse reactions associated with the substrates. If ORLADEYO is concomitantly used with CYP2D6 or CYP3A4 substrates where minimal increases in the concentration of the substrates may lead to serious adverse reactions, closely monitor or modify the dosage of the CYP2D6 or CYP3A4 substrate.
The safety and effectiveness of ORLADEYO in pediatric patients <2 years of age have not been established.
There are insufficient data available to inform drug-related risks with ORLADEYO use in pregnancy. There are no data on the presence of berotralstat in human milk, its effects on the breastfed infant, or its effects on milk production.
To report SUSPECTED ADVERSE REACTIONS, contact BioCryst Pharmaceuticals, Inc. at 1-833-633-2279 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch.
About BioCryst Pharmaceuticals
BioCryst is a global biotechnology company focused on developing and commercializing medicines for hereditary angioedema (“HAE”) and other rare diseases, driven by its deep commitment to improving the lives of people living with these conditions. BioCryst has commercialized ORLADEYO® (berotralstat), the first oral, once-daily plasma kallikrein inhibitor, and is advancing a pipeline of potential first-in-class or best-in-class oral small-molecule and injectable protein therapeutics for a range of rare diseases. For more information, please visit www.biocryst.com or follow us on LinkedIn.
Forward-Looking Statements
This press release contains forward-looking statements, including statements regarding new clinical trial data, real-world outcomes and expectations with respect to BioCryst’s HAE portfolio and the potential dosing profile, competitive positioning, and expectations for navenibart. These statements involve known and unknown risks, uncertainties and other factors which may cause actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. These statements reflect our current views with respect to future events and are based on assumptions and are subject to risks and uncertainties. Given these uncertainties, you should not place undue reliance on these forward-looking statements. Some of the factors that could affect the forward-looking statements contained herein include: risks related to the development and interpretation of clinical and real-world data; BioCryst’s ability to successfully implement or maintain its commercialization plans for ORLADEYO and successfully commercialize future products; BioCryst’s ability to successfully progress its development plans for navenibart; the outcome of preclinical testing and early clinical trials may not be predictive of the success of later clinical trials, and interim results of a clinical trial do not necessarily predict final results; ongoing and future clinical development of product candidates, including navenibart, may take longer than expected and may not have positive results; the FDA or other applicable regulatory agencies may require additional studies beyond the studies planned for navenibart, may not provide regulatory clearances which may result in delay of planned clinical trials, may not review regulatory filings on our expected timeline, may impose certain restrictions, warnings, or other requirements, may impose a clinical hold, or may withhold, delay or withdraw market approval, may ultimately determine that there are deficiencies in the development program or execution thereof, may require additional information or studies, may disagree with our safety and efficacy conclusions, or may impose certain restrictions, warnings, or other requirements; and risks related to the expected dosing or best-in-class profile of navenibart. This list is not exclusive. To see a more comprehensive set of risks, please refer to the documents BioCryst files periodically with the Securities and Exchange Commission, specifically BioCryst’s most recent Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K, which identify important factors that could cause actual results to differ materially from those contained in BioCryst’s forward-looking statements.
Extreme Networks (EXTR - Free Report) closed the last trading session at $17.59, gaining 15.3% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $23.38 indicates a 32.9% upside potential.
The average comprises eight short-term price targets ranging from a low of $17.00 to a high of $26.00, with a standard deviation of $2.97. While the lowest estimate indicates a decline of 3.4% from the current price level, the most optimistic estimate points to a 47.8% upside. More than the range, one should note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.
While the consensus price target is highly sought after by investors, the ability and unbiasedness of analysts in setting price targets have long been questionable. And investors making investment decisions solely based on this tool would arguably do themselves a disservice.
But, for EXTR, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.
Price, Consensus and EPS Surprise
Here's What You May Not Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.
While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?
They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.
However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.
That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.
Here's Why There Could be Plenty of Upside Left in EXTRThere has been increasing optimism among analysts lately about the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher. And that could be a legitimate reason to expect an upside in the stock. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
The Zacks Consensus Estimate for the current year has increased 2.2% over the past month, as one estimate has gone higher compared to no negative revision.
Moreover, EXTR currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Therefore, while the consensus price target may not be a reliable indicator of how much EXTR could gain, the direction of price movement it implies does appear to be a good guide.
Key Takeaways AEIS is set to report Q1 2026 results in May with revenue seen around $500M and strong YoY growth. AEIS is benefiting from semiconductor and AI-driven data center demand, boosting shares sharply YTD. AEIS faces supply chain constraints and tariff-driven cost pressures that may weigh on margins. Advanced Energy Industries (AEIS - Free Report) is scheduled to release first-quarter 2026 results on May 4.
For the first quarter of 2026, Advanced Energy expects revenues of $500 million (+/- $20 million). The company expects non-GAAP earnings of $1.94 per share (+/- 25 cents).
The Zacks Consensus Estimate for first-quarter revenues is currently pegged at $508.20 million, indicating growth of 25.61% from the figure reported in the year-ago quarter. The consensus mark for earnings is currently pegged at $1.96 per share, unchanged over the past 30 days. The figure indicates a 59.35% increase from the year-ago quarter’s reported figure.
Advanced Energy beat the Zacks Consensus Estimate for earnings in the trailing four quarters, delivering an average surprise of 15.86%.
Let us see how things have shaped up for the upcoming announcement.
Factors Likely to Have Influenced AEIS’s Q1 PerformanceAEIS shares have surged 85% in the year-to-date period, driven by higher demand for its solutions in the semiconductor and data center computing markets. In the latter end-market, the company has been benefiting from strong AI-driven demand from hyperscalers, a trend expected to have continued in the to-be-reported quarter.
AEIS expects sequential revenue growth primarily from the semiconductor segment in the first quarter of 2026. Customer forecasts have improved, and new product revenue is anticipated to increase throughout the year, underpinned by investments in advanced logic and memory capacity. The company has achieved significant design wins, especially with its eVerest, eVoS, and NavX technologies, which are solving critical customer challenges at advanced nodes (sub-2nm).
The company projects first-quarter 2026 data center computing revenues to be similar to the fourth quarter of 2025, with expectations for revenue to strengthen through the year as new programs ramp up. An expanded capacity driven by facilities in the Philippines and Mexico has been helping the company keep up with strong demand in the data center computing end market.
The Industrial and Medical segment is expected to be flattish in the to-be-reported due to typical seasonality, but the outlook remains positive for continued growth over the next several quarters.
However, AEIS is expected to have suffered from ongoing supply chain constraints, especially in processors and memory, which could limit growth, as well as potential margin pressure from tariffs and higher operating expenses.
What Our Model SaysAccording to the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is not the case here.
AEIS currently has an Earnings ESP of 0.00% and a Zacks Rank #2. You can uncover the best stocks to buy or sell before they are reported with our Earnings ESP Filter.
Stocks to ConsiderHere are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings in their upcoming releases:
Sandisk (SNDK - Free Report) has an Earnings ESP of +4.96% and a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Sandisk is set to report third-quarter fiscal 2026 results on April 30. Sandisk shares have increased 317.1% in the year-to-date period.
Audioeye (AEYE - Free Report) has an Earnings ESP of +9.62% and a Zacks Rank #2 at present. Audioeye is likely to report its first-quarter 2026 results on May 13. Audioeye shares have decreased 27.4% in the year-to-date period.
Extreme Networks (EXTR - Free Report) has an Earnings ESP of +1.41% and a Zacks Rank #2. Extreme Networks is set to report its third-quarter 2026 results on April 29. Extreme Networks' shares have increased 5.7% in the year-to-date period.
Key Takeaways Cognizant is set to report Q1 2026 results with EPS expected to rise 8.13% year over year. CTSH growth is driven by strong bookings, large deals, and rising GenAI demand across industries. Cognizant faces headwinds from weak segment demand and macro-driven spending pressures. Cognizant Technology Solutions (CTSH - Free Report) is scheduled to report its first-quarter 2026 results on April 29, 2026.
The Zacks Consensus Estimate for first-quarter 2026 earnings is pegged at $1.33 per share, decreased by a penny over the past 30 days. This represents an 8.13% increase from the figure reported in the year-ago quarter.
Cognizant expects first-quarter 2026 revenues between $5.36 billion and $5.44 billion, indicating growth of 4.8%-6.3% and an increase of 2.7%-4.2% on a cc basis.
The Zacks Consensus Estimate for first-quarter revenues is pegged at $5.41 billion, indicating a year-over-year increase of 5.81%.
Cognizant’s earnings surpassed the Zacks Consensus Estimate in the trailing four quarters, the average surprise being 4.34%.
Let’s see how things have shaped up for the upcoming announcement.
Factors to NoteCognizant’s first-quarter 2026 performance is likely to have benefited from an expanding client base and a robust pipeline, including a favorable mix of new opportunities. On a trailing 12-month basis, bookings increased 5% year over year to $28.4 billion, which represented a book-to-bill of approximately 1.3 times. Bookings in the fourth quarter increased 9% year over year. Fourth-quarter bookings included 12 large deals, with a total contract value of more than $100 million, of which two were mega deals, or deals with a total contract value of more than $500 million.These deals are expected to have contributed to revenue growth in the to-be-reported quarter.
The growing demand for GenAI solutions across industries like financial services, healthcare, and manufacturing is expected to provide continued growth opportunities in the first quarter of 2026, particularly in areas like fraud detection, medical imaging, and predictive maintenance. Cognizant had more than 4,000 early Generative AI client engagements in the fourth quarter of 2025.
The recently completed acquisition of 3Cloud is another key factor expected to benefit CTSH in the first quarter. This acquisition adds over 1,200 Azure specialists and engineers, strengthening CTSH’s capabilities in Azure, data, AI, and application innovation. The integration of 3Cloud is expected to have contributed approximately 100 basis points to the first quarter of 2026 revenue growth, further supporting the company’s inorganic growth strategy and expanding its expertise in cloud and AI services.
CTSH’s NextGen initiative is expected to have played a pivotal role in enhancing operational efficiency in the to-be-reported quarter.
However, CTSH is suffering from weak demand in the products and resources segment, which was due to tariff policy concerns and spending pressures. Macroeconomic uncertainties, muted discretionary spending, and ongoing cost optimization pressures across some sectors remain a concern.
What Our Model SaysPer the Zacks model, the combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy), or 3 (Hold) increases the odds of an earnings beat. But that is not the case here.
Cognizant has an Earnings ESP of -0.99% and a Zacks Rank #4 (Sell). You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Stocks to ConsiderHere are some companies worth considering, as our model shows that these have the right combination of elements to beat on earnings in their upcoming releases:
Sandisk (SNDK - Free Report) has an Earnings ESP of +4.96% and a Zacks Rank #1 at present. You can see the complete list of today’s Zacks #1 Rank stocks here. Sandisk is set to report third-quarter fiscal 2026 results on April 30. Sandisk shares have increased 317.1% in the year-to-date period.
Audioeye (AEYE - Free Report) has an Earnings ESP of +9.62% and a Zacks Rank #2 at present. Audioeye is likely to report its first-quarter 2026 results on May 13. Audioeye shares have decreased 27.4% in the year-to-date period.
Extreme Networks (EXTR - Free Report) has an Earnings ESP of +1.41% and a Zacks Rank #2. Extreme Networks is set to report its third-quarter 2026 results on April 29. Extreme Networks' shares have increased 5.7% in the year-to-date period.
MORRISVILLE, N.C.--(BUSINESS WIRE)--Extreme Networks, Inc. (“Extreme”) (Nasdaq: EXTR) today released financial results for its third quarter of fiscal 2026 ended March 31, 2026.
“Our fifth straight quarter of double-digit growth highlights strong momentum, fueled by disciplined execution, differentiated technology, and rising demand for our AI-powered platform. We’ve fully addressed our current and longer-term supply chain needs, including memory, through targeted sourcing strategies, product redesign, and strategic purchase commitments. These actions position us for continued share gains and growth. This quarter’s results reflect not just our performance today, but the strength and scalability of our strategy going forward,” said Ed Meyercord, President and CEO of Extreme.
“SaaS ARR growth accelerated, reflecting rising adoption and deeper customer engagement with Extreme Platform ONE. This momentum underscores the power of our platform approach and the shift toward a more predictable, recurring revenue model. It’s a clear signal that customers are standardizing on our platform to drive automation, boost productivity, and scale their operations,” said Meyercord.
Kevin Rhodes, Executive Vice President and Chief Financial Officer, noted, “The third quarter marked our eighth consecutive quarter of sequential product revenue growth, reflecting continued execution and share gains. Enterprise networking demand remains resilient, and the targeted pricing actions we implemented are successfully offsetting the incremental supply chain costs we have incurred. Together, these actions underpin our gross margin results and outlook. In addition, we returned $50 million to shareholders through an accelerated share repurchase, underscoring our confidence in the durability of our operating model and cash flow generation.”
Fiscal Third Quarter Results:
Revenue $316.9 million, up 11% year-over-year and relatively flat quarter-over-quarter SaaS ARR $236.4 million, up 28.6% year-over-year and 4.2% quarter-over-quarter GAAP diluted EPS $0.08, compared to $0.03 last year and $0.06 last quarter Non-GAAP diluted EPS $0.26, compared to $0.21 last year and $0.26 last quarter GAAP gross margin 61.7%, compared to 61.7% last year and 61.4% last quarter Non-GAAP gross margin 62.3%, compared to 62.3% last year and 62.0% last quarter GAAP operating margin 5.5%, compared to 3.6% last year and 4.1% last quarter Non-GAAP operating margin 15.2%, compared to 14.1% last year and 15.0% last quarter Share repurchases of $50.0 million during the quarter Liquidity:
Q3 ending cash balance was $210.1 million, a decrease of $9.7 million from the end of Q2 2026 and an increase of $24.6 million from the end of Q3 in the prior year. Q3 net cash was $11.3 million, as compared to net cash of $47.3 million at the end of Q2 2026 and net cash of $3.0 million at the end of Q3 in the prior year. Recent Key Highlights:
Extreme supported Lucas Oil Stadium in Indianapolis for the NCAA Men’s Final Four and rapidly modernized connectivity by removing legacy access points and deploying temporary infrastructure to ensure the venue was fully game-ready on an accelerated timeline. With Wi-Fi 7 from Extreme coming in time for the upcoming Indianapolis Colts season, this upgrade will enhance stadium operations through faster, more reliable network performance for ticketing, security, and concessions, while elevating the fan experience with seamless high-speed connectivity for streaming and mobile engagement. Extreme secured several new Extreme Platform ONE wins during the quarter, including Asiana Airlines, Atlantic Food Distributors, Bridgeport Public Schools, City of Prescott (AZ), Johnstone Supply, Nissha Medical Technologies, and the University of Buckingham. These customers are leveraging AI-powered automation to reduce manual tasks, streamline operations, minimize network complexity, and enable faster execution at lower cost. Extreme continues to gain share within the UK National Health Service, with a new win at South London and Maudsley NHS Foundation Trust, where Extreme displaced a larger Chinese competitor. Fabric played a key role by delivering secure segmentation to protect patient data and devices. NHS selected Extreme’s one-license, one-device model for its simplicity and predictable cost. London Business School is deploying a full-stack Extreme solution to modernize networking across a complex urban campus spanning historic and modern academic buildings. The solution includes Extreme Platform ONE and wired and wireless platforms. Using Extreme Fabric, the school is automating and unifying the network across dorms, labs, and academic buildings, simplifying deployment while ensuring consistent security policies. Extreme Platform ONE provides unified management and security, while high-performance Wi-Fi 7 enables secure, seamless connectivity for students, faculty, and staff across campus. Extreme is enhancing the fan experience for the Carolina Hurricanes at the Lenovo Center with a full Wi-Fi 7 upgrade, replacing legacy Wi-Fi 5 to deliver faster, more reliable connectivity throughout the arena. Fiscal Q3 2026 Financial Results:
(in millions, except percentages and per share information)
GAAP Results
Three Months Ended
March 31, 2026
March 31, 2025
Change
Product
$
199.4
$
178.1
$
21.3
Subscription and support
117.5
106.4
11.1
Total net revenue
$
316.9
$
284.5
$
32.4
Gross margin
61.7
%
61.7
%
0.0
%
Operating margin
5.5
%
3.6
%
1.9
%
Net income
$
10.6
$
3.5
$
7.1
Net income per diluted share
$
0.08
$
0.03
$
0.05
Non-GAAP Results
Three Months Ended
March 31, 2026
March 31, 2025
Change
Product
$
199.4
$
178.1
$
21.3
Subscription and support
117.5
106.4
11.1
Total net revenue
$
316.9
$
284.5
$
32.4
Gross margin
62.3
%
62.3
%
0.0
%
Operating margin
15.2
%
14.1
%
1.1
%
Net income
$
34.8
$
28.0
$
6.8
Net income per diluted share
$
0.26
$
0.21
$
0.05
Extreme uses the non-GAAP free cash flow metric as a measure of operating performance. Free cash flow represents GAAP net cash provided by operating activities, less purchases of property, equipment and capitalized software development costs. Extreme considers free cash flow to be useful information for management and investors regarding the amount of cash generated by the business after the purchases of property, equipment and capitalized software development costs, which can then be used to, among other things, invest in Extreme’s business, make strategic acquisitions, and strengthen the balance sheet. A limitation of the utility of this non-GAAP free cash flow metric as a measure of financial performance is that it does not represent the total increase or decrease in the Company’s cash balance for the period. The following table shows the non-GAAP free cash flow calculation (in millions):
Free Cash Flow
Three Months Ended
March 31, 2026
March 31, 2025
Cash flow provided by operations
$
14.2
$
30.0
Less: Capital expenditures for property, equipment and capitalized software development costs
(6.4
)
(5.8
)
Total free cash flow
$
7.8
$
24.2
SaaS ARR: SaaS annual recurring revenue (“SaaS ARR”) represents the annualized value of our subscription offerings and the renewable, term-based license portion of software license arrangements. SaaS ARR excludes perpetual licenses, upfront license fees, variable or non-recurring revenue, professional services revenue, support revenue from maintenance contracts, and other non-subscription revenue. SaaS ARR reflects the annual recurring revenue associated with Extreme Platform ONE (which includes embedded support), ExtremeCloud IQ, and other subscription revenue, based on the annualized value of quarterly subscription revenue and the trailing twelve months of term-based license revenue. Management uses SaaS ARR to evaluate the scale and trajectory of the Company’s subscription-based offerings and progress against customer adoption initiatives. We believe this metric is useful to investors for the same reasons, as it provides insight into our ability to acquire new customers and to maintain and expand our existing customer relationships. SaaS ARR is an operating metric and should be considered independently of revenue or deferred revenue determined in accordance with U.S. GAAP. SaaS ARR does not have a standardized meaning and therefore may not be comparable to similarly titled measures presented by other companies. SaaS ARR is not intended to be a replacement for, or a forecast of, revenue.
Gross debt: Gross debt is defined as long-term debt and the current portion of long-term debt as shown on the balance sheet plus unamortized debt issuance costs, if any.
Net cash: is defined as cash and cash equivalents minus gross debt, as shown in the table below (in millions):
Cash and cash equivalents
Gross debt
Net cash
$
210.1
$
198.8
$
11.3
Business Outlook:
Extreme’s business outlook is based on current expectations. The following statements are forward-looking, and actual results could differ materially based on various factors, including market conditions and the factors set forth under “Forward-Looking Statements” below.
For its fourth quarter fiscal 2026, ending June 30, 2026, the Company is targeting:
(in millions, except percentages and per share information)
Low-End
High-End
FQ4'26 Guidance – GAAP
Total net revenue
$
330.0
$
335.0
Gross margin
61.2
%
61.6
%
Operating margin
6.1
%
7.1
%
Earnings per share
$
0.12
$
0.15
Diluted shares outstanding used in calculating GAAP EPS
131.8
131.8
FQ4'26 Guidance – Non-GAAP
Total net revenue
$
330.0
$
335.0
Gross margin
61.8
%
62.2
%
Operating margin
15.2
%
16.1
%
Earnings per share
$
0.28
$
0.30
Diluted shares outstanding used in calculating non-GAAP EPS
131.8
131.8
The following table shows the GAAP to non-GAAP reconciliation for Q4 FY'26 guidance:
FQ4'26
Gross Margin
Operating Margin
Earnings per Share
GAAP
61.2% - 61.6%
6.1% - 7.1%
$0.12 - $0.15
Estimated adjustments for:
Share-based compensation
0.5%
7.0% - 7.1%
0.18
Amortization of product intangibles
0.1%
0.1%
0.00
Amortization of non-product intangibles
—
0.1%
0.00
Litigation charges
—
0.9%
0.02
System transition costs
—
0.9%
0.02
Tax adjustment
—
—
(0.07) - (0.06)
Non-GAAP
61.8% - 62.2%
15.2% - 16.1%
$0.28 - $0.30
The total percentage rate changes may not equal the total change in all cases due to rounding.
For the full year fiscal 2026, ending June 30, 2026, the Company is targeting:
(in millions, except percentages and per share information)
Low-End
High-End
FY'26 Guidance
Total net revenue
$
1,275.0
$
1,280.0
Gross margin
61.2
%
61.3
%
Operating margin
4.8
%
5.1
%
Earnings per share
$
0.30
$
0.33
Diluted shares outstanding used in calculating GAAP EPS
133.9
133.9
FY'26 Guidance – Non-GAAP
Total net revenue
$
1,275.0
$
1,280.0
Gross margin
61.8
%
61.9
%
Operating margin
14.7
%
14.9
%
Earnings per share
$
1.02
$
1.04
Diluted shares outstanding used in calculating non-GAAP EPS
133.9
133.9
The following table shows the GAAP to non-GAAP reconciliation for FY'26 guidance:
FY'26
Gross Margin
Operating Margin
Earnings per Share
GAAP
61.2% - 61.3%
4.8% - 5.1%
$0.30 - $0.33
Estimated adjustments for:
Share-based compensation
0.5%
7.1% - 7.2%
0.67
Amortization of product intangibles
0.1%
0.1%
0.01
Amortization of non-product intangibles
—
0.1%
0.01
Other non-recurring costs
—
0.3%
0.03
Litigation charges
—
0.5%
0.05
System transition costs
—
1.7%
0.16
Tax adjustment
—
—
(0.22) - (0.21)
Non-GAAP
61.8% - 61.9%
14.7% - 14.9%
$1.02 - $1.04
The total percentage rate changes may not equal the total change in all cases due to rounding.
Conference Call:
Extreme will host a conference call at 8:00 a.m. Eastern (5:00 a.m. Pacific) today to review the third quarter results of fiscal 2026 as well as the business outlook for the fourth quarter of fiscal 2026 and the full year fiscal 2026, ending June 30, 2026, including significant factors and assumptions underlying the targets noted above. The conference call will be available to the public through a live audio web broadcast via the internet at http://investor.extremenetworks.com and a replay of the call will be available on the website for at least 7 days following the call. To access the call, please go to this link (Registration Link) and you will be provided with dial in details. If you would like to participate in the Q&A, please register here: Q&A Registration Link. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time.
About Extreme:
Extreme Networks, Inc. (EXTR) is a leader in AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. We push the boundaries of technology, leveraging the powers of artificial intelligence, analytics, and automation. Tens of thousands of customers globally trust our AI-driven cloud networking solutions and industry-leading support to enable businesses to drive value, foster innovation, and overcome extreme challenges. For more information, visit Extreme’s website at https://www.extremenetworks.com/ or LinkedIn, YouTube, X (Formerly Twitter), Facebook or Instagram.
Extreme Networks, ExtremeCloud, Extreme Platform ONE, and the Extreme Networks logo, are trademarks of Extreme Networks, Inc. or its subsidiaries in the United States and/or other countries. Other trademarks shown herein are the property of their respective owners.
Non-GAAP Financial Measures:
Extreme provides all financial information required in accordance with U.S. generally accepted accounting principles (“GAAP”). The Company is providing with this press release non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income per diluted share, adjusted EBITDA, net cash and free cash flow. In preparing non-GAAP information, the Company has excluded, where applicable, the impact of share-based compensation, amortization of intangibles, restructuring and related charges, system transition costs, litigation charges, other non-recurring costs, debt refinancing charges and the tax effect of non-GAAP adjustments. The Company believes that excluding these items provides both management and investors with additional insight into its current operations, the trends affecting the Company, the Company’s marketplace performance, and the Company’s ability to generate cash from operations. Please note the Company’s non-GAAP measures may be different than those used by other companies. The additional non-GAAP financial information the Company presents should be considered in conjunction with, and not as a substitute for, the Company’s GAAP financial information.
The Company has provided a non-GAAP reconciliation of the results for the periods presented in this release, which are adjusted to exclude certain items as indicated. These measures should only be used to evaluate the Company’s results of operations in conjunction with the corresponding GAAP measures for comparable financial information and understanding of the Company’s ongoing performance as a business. Extreme uses both GAAP and non-GAAP measures to evaluate and manage its operations.
Forward-Looking Statements:
This press release contains ‘forward-looking statements’ within the meaning of the Private Securities Litigation Reform Act of 1995, including, among others, statements regarding our outlook, targets, and guidance; our expectations regarding demand, product adoption, competitive dynamics, revenues, margins, cash flow and other operating or financial results; and our plans, objectives and assumptions. These forward-looking statements speak only as of the date of this release. There are several important factors that could cause actual results and other future events to differ materially from those suggested or indicated by such forward-looking statements. These include, among others, risks related to global macroeconomic, industry and business trends; variability in demand, sales cycles and pipeline conversion; the Company’s failure to achieve targeted financial metrics; a highly competitive business environment for network switching equipment and cloud management of network devices; supply chain challenges and component shortages; the Company’s effectiveness in controlling expenses; the possibility that the Company might experience delays in the development or introduction of new technology and products; customer response to the Company’s new technology and products; risks related to pending or future litigation; political and geopolitical factors, including the possible impact of tariffs and changes to U.S. tax regulations; and a dependency on third parties for certain components and for the manufacturing of the Company’s products.
For more information about factors that could cause actual results and other future events to differ materially from those suggested or indicated by such forward-looking statements, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” and “Risk Factors” included in the Company’s Annual Report on Form 10-K, Quarterly Reports on Form 10-Q, and other documents of the Company on file with the Securities and Exchange Commission (available at www.sec.gov). As a result of these risks and others, actual results could vary significantly from those anticipated in this press release, and the Company’s financial condition and results of operations could be materially adversely affected. Except as required under the U.S. federal securities laws and the rules and regulations of the Securities and Exchange Commission, Extreme disclaims any obligation to update any forward-looking statements after the date of this release, whether as a result of new information, future events, developments, changes in assumptions or otherwise.
EXTREME NETWORKS, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands, except per share amounts)
(Unaudited)
March 31, 2026
June 30, 2025
ASSETS
Current assets:
Cash and cash equivalents
$
210,113
$
231,745
Accounts receivable, net
162,710
126,708
Inventories
76,634
102,578
Prepaid expenses and other current assets
92,345
74,265
Total current assets
541,802
535,296
Property and equipment, net
53,544
44,366
Operating lease right-of-use assets, net
32,508
38,655
Goodwill
398,211
399,574
Intangible assets, net
3,840
6,541
Other assets
140,155
128,786
Total assets
$
1,170,060
$
1,153,218
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable
$
81,157
$
63,939
Accrued compensation and benefits
48,669
62,895
Accrued warranty
10,139
9,684
Current portion of deferred revenue
334,598
325,078
Current portion of long-term debt, net of unamortized debt issuance costs of $679 and $729, respectively
48,071
14,271
Current portion of operating lease liabilities
12,275
11,456
Other accrued liabilities
58,356
100,552
Total current liabilities
593,265
587,875
Deferred revenue, less current portion
312,515
292,415
Long-term debt, less current portion, net of unamortized debt issuance costs of $777 and $1,276, respectively
149,223
163,724
Operating lease liabilities, less current portion
26,170
33,991
Deferred income taxes
7,343
7,033
Other long-term liabilities
2,579
2,596
Commitments and contingencies
Stockholders’ equity:
Convertible preferred stock, $0.001 par value, issuable in series, 2,000 shares authorized; none issued
—
—
Common stock, $0.001 par value, 750,000 shares authorized; 156,657 and 152,673 shares issued, respectively; 132,513 and 132,064 shares outstanding, respectively
157
153
Additional paid-in capital
1,350,759
1,298,791
Accumulated other comprehensive loss
(15,684
)
(8,137
)
Accumulated deficit
(925,352
)
(949,429
)
Treasury stock at cost, 24,144 shares and 20,609 shares, respectively
(330,915
)
(275,794
)
Total stockholders’ equity
78,965
65,584
Total liabilities and stockholders’ equity
$
1,170,060
$
1,153,218
EXTREME NETWORKS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(In thousands, except per share amounts)
(Unaudited)
Three Months Ended
Nine Months Ended
March 31,
2026
March 31,
2025
March 31,
2026
March 31,
2025
Net revenues:
Product
$
199,345
$
178,060
$
591,151
$
512,605
Subscription and support
117,529
106,445
353,893
320,459
Total net revenues
316,874
284,505
945,044
833,064
Cost of revenues:
Product
86,206
76,059
259,334
218,065
Subscription and support
35,124
33,037
107,057
94,960
Total cost of revenues
121,330
109,096
366,391
313,025
Gross profit:
Product
113,139
102,001
331,817
294,540
Subscription and support
82,405
73,408
246,836
225,499
Total gross profit
195,544
175,409
578,653
520,039
Operating expenses:
Research and development
59,184
55,656
174,459
164,990
Sales and marketing
88,979
79,773
267,295
241,123
General and administrative
29,634
29,537
93,420
92,202
Restructuring and related charges (benefit)
—
(441
)
538
1,871
Amortization of intangible assets
407
507
1,314
1,528
Total operating expenses
178,204
165,032
537,026
501,714
Operating income
17,340
10,377
41,627
18,325
Interest income
983
972
3,312
2,657
Interest expense
(3,249
)
(3,797
)
(10,262
)
(12,398
)
Other expense, net
(263
)
(385
)
(1,110
)
(445
)
Income before income taxes
14,811
7,167
33,567
8,139
Provision for income taxes
4,221
3,709
9,490
7,803
Net income
$
10,590
$
3,458
$
24,077
$
336
Basic and diluted income per share:
Net income per share – basic
$
0.08
$
0.03
$
0.18
$
0.00
Net income per share – diluted
$
0.08
$
0.03
$
0.18
$
0.00
Shares used in per share calculation – basic
132,931
132,979
133,275
132,173
Shares used in per share calculation – diluted
133,591
134,590
134,917
133,770
EXTREME NETWORKS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
Nine Months Ended
March 31, 2026
March 31, 2025
Cash flows from operating activities:
Net income
$
24,077
$
336
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation
11,600
11,261
Amortization of intangible assets
2,631
3,356
Amortization of cloud computing implementation costs
2,848
—
Reduction in carrying amount of right-of-use asset
7,710
7,386
Provision for credit losses
430
85
Share-based compensation
66,447
61,573
Deferred income taxes
658
(879
)
Provision for excess and obsolete inventory
4,639
1,616
Non-cash interest expense
907
902
Other
1,393
703
Changes in operating assets and liabilities:
Accounts receivable, net
(36,432
)
(10,113
)
Inventories
19,012
14,445
Prepaid expenses and other assets
(38,488
)
(20,331
)
Accounts payable
16,388
(3,982
)
Accrued compensation and benefits
(15,927
)
1,302
Operating lease liabilities
(8,532
)
(8,060
)
Deferred revenue
33,299
17,746
Other current and long-term liabilities
(42,327
)
(7,254
)
Net cash provided by operating activities
50,333
70,092
Cash flows from investing activities:
Capital expenditures for property, equipment and capitalized software development costs
(20,364
)
(18,067
)
Net cash used in investing activities
(20,364
)
(18,067
)
Cash flows from financing activities:
Borrowings under revolving facility
55,000
—
Payments on revolving facility
(25,000
)
—
Payments on debt obligations
(11,250
)
(7,500
)
Payments on debt financing costs
—
(695
)
Repurchase of common stock including accelerated share repurchases
(62,000
)
(13,000
)
Payments for tax withholdings, net of proceeds from issuance of common stock
(7,596
)
(1,907
)
Net cash used in financing activities
(50,846
)
(23,102
)
Foreign currency effect on cash and cash equivalents
(755
)
(142
)
Net increase (decrease) in cash and cash equivalents
(21,632
)
28,781
Cash and cash equivalents at beginning of period
231,745
156,699
Cash and cash equivalents at end of period
$
210,113
$
185,480
Extreme Networks, Inc.
Non-GAAP Measures of Financial Performance
To supplement the Company’s consolidated financial statements presented in accordance with U.S. generally accepted accounting principles (“GAAP”), Extreme uses non-GAAP measures of certain components of financial performance. These non-GAAP measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating margin, non-GAAP operating income, non-GAAP net income, non-GAAP net income per diluted share, adjusted EBITDA (calculated as GAAP net income excluding interest, income taxes, depreciation and amortization as well as costs or benefits that are not reflective of the Company’s ongoing or expected future operational performance as noted below), net cash and free cash flow.
Reconciliation to the nearest GAAP measure of all historical non-GAAP measures included in this press release can be found in the tables included with this press release.
Non-GAAP measures presented in this press release are not in accordance with or alternative measures prepared in accordance with GAAP and may be different from non-GAAP measures used by other companies. In addition, these non-GAAP measures are not based on any comprehensive set of accounting rules or principles. Non-GAAP measures have limitations in that they do not reflect all of the amounts associated with Extreme’s results of operations as determined in accordance with GAAP. These non-GAAP measures should only be used to evaluate Extreme’s results of operations in conjunction with the corresponding GAAP measures.
Extreme believes these non-GAAP measures, when shown in conjunction with the corresponding GAAP measures, enhance investors’ and management’s overall understanding of the Company’s current financial performance and the Company’s prospects for the future, including cash flows available to pursue opportunities to enhance stockholder value. In addition, because Extreme has historically reported certain non-GAAP results to investors, the Company believes the inclusion of non-GAAP measures provides consistency in the Company’s financial reporting.
For its internal planning process, and as discussed further below, Extreme’s management uses financial statements that do not include share-based compensation expense, amortization of intangibles, restructuring and related charges, system transition costs, litigation charges, other non-recurring costs, debt refinancing charges, and the tax effect of non-GAAP adjustments. Extreme’s management also uses non-GAAP measures, in addition to the corresponding GAAP measures, in reviewing the Company’s financial results.
As described above, Extreme excludes the following items from one or more of its non-GAAP measures when applicable.
Share-based compensation. Share-based compensation consists of associated expenses for stock options, restricted stock awards and the Company’s Employee Stock Purchase Plan. Extreme excludes share-based compensation expenses from its non-GAAP measures primarily because they are non-cash expenses that the Company does not believe are reflective of ongoing cash requirement related to its operating results. Extreme expects to incur share-based compensation expenses in future periods.
Amortization of intangibles. Amortization of intangibles includes the monthly amortization expense of intangible assets such as developed technology, customer relationships and trademarks. The amortization of the developed technology are recorded in cost of goods sold, while the amortization for the other intangibles are recorded in operating expenses. Extreme excludes these expenses since they result from an intangible asset and for which the period expense does not impact the operations of the business and are non-cash in nature.
Restructuring and related charges. Restructuring and related charges consist of severance costs for employees, asset disposal costs and other charges related to excess facilities that do not provide economic benefit to our future operations. Extreme excludes restructuring expenses since they result from events that occur outside of the ordinary course of continuing operations.
System transition costs. System transition costs consist of costs related to direct and incremental costs incurred in connection with our multi-phase transition of our customer relationship management solution, our configure, price, quote solution and our enterprise resource planning tools that were not capitalizable. Extreme excludes these costs because we believe that these costs do not reflect future operating expenses and will be inconsistent in amount and frequency, making it difficult to contribute to a meaningful evaluation of our operating performance.
Litigation charges. Litigation charges consist of estimated settlement and related legal expenses for non-recurring litigations offset by any proceeds received or expected to be received from insurance.
Debt refinancing charges. Debt refinancing charges consist of costs that were not capitalizable and are included in other expense, net, that occurred in conjunction with the amendments related to our outstanding credit facility.
Other non-recurring costs. Other non-recurring costs consist of certain external advisory and professional fees incurred for various non-recurring transactions and activities that occur outside of the normal course of business. Extreme excludes these costs because we believe that these costs do not reflect future operating expenses and will be inconsistent in amount and frequency, making it difficult to contribute to a meaningful evaluation of our operating performance.
Tax effect of non-GAAP adjustments. We calculate our non-GAAP provision for income taxes in accordance with the SEC guidance on non-GAAP Financial Measures Compliance and Disclosure Interpretation. We have assumed our U.S. federal and state net operating losses would have been fully consumed by the historical non-GAAP financial adjustments, eliminating the need for a full valuation allowance against our U.S. deferred tax assets which, consequently, enables our use of research and development tax credits. The non-GAAP tax provision consists of current and deferred income tax expense commensurate with the non-GAAP measure of profitability using our blended U.S. statutory tax rate of 24.6%.
The non-GAAP provision for income taxes has typically been and is currently higher than the GAAP provision given the Company has a valuation allowance against its US and a portion of its Irish deferred tax assets due to historical losses. Once these valuation allowances are released, the non-GAAP and the GAAP provision for income taxes will be more closely aligned.
Over the next year, our cash taxes will be driven by US federal and state taxes and the tax expense of our foreign subsidiaries, which amounts have not historically been significant, with the exception of the Company’s Canadian, German and Indian subsidiaries which perform research and development and sales and marketing activities for the Company, as well as the Company’s Irish trading subsidiaries.
EXTREME NETWORKS, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
GAAP TO NON-GAAP RECONCILIATION
(In thousands, except percentages and per share amounts)
(Unaudited)
Revenues
Three Months Ended
Nine Months Ended
March 31,
2026
March 31,
2025
March 31,
2026
March 31,
2025
Revenues – GAAP
$
316,874
$
284,505
$
945,044
$
833,064
Non-GAAP Gross Margin
Three Months Ended
Nine Months Ended
March 31,
2026
March 31,
2025
March 31,
2026
March 31,
2025
Gross profit – GAAP
$
195,544
$
175,409
$
578,653
$
520,039
Gross margin – GAAP percentage
61.7
%
61.7
%
61.2
%
62.4
%
Adjustments:
Share-based compensation expense, Product
755
663
2,303
1,961
Share-based compensation expense, Subscription and support
723
706
2,209
2,193
Amortization of intangibles, Product
336
580
1,264
1,775
Total adjustments to GAAP gross profit
$
1,814
$
1,949
$
5,776
$
5,929
Gross profit – non-GAAP
$
197,358
$
177,358
$
584,429
$
525,968
Gross margin – non-GAAP percentage
62.3
%
62.3
%
61.8
%
63.1
%
Non-GAAP Operating Margin
Three Months Ended
Nine Months Ended
March 31,
2026
March 31,
2025
March 31,
2026
March 31,
2025
GAAP operating income
$
17,340
$
10,377
$
41,627
$
18,325
GAAP operating margin
5.5
%
3.6
%
4.4
%
2.2
%
Adjustments:
Share-based compensation expense, cost of revenues
1,478
1,369
4,512
4,154
Share-based compensation expense, R&D
4,267
4,178
13,353
12,858
Share-based compensation expense, S&M
7,564
6,963
23,086
21,441
Share-based compensation expense, G&A
8,459
7,844
25,496
23,120
Restructuring and related charges (benefit)
—
(441
)
538
1,871
Litigation charges
376
1,123
3,135
12,716
System transition costs
7,556
7,548
18,948
16,919
Amortization of intangibles
743
1,087
2,578
3,303
Other non-recurring costs
231
—
3,879
—
Total adjustments to GAAP operating income
$
30,674
$
29,671
$
95,525
$
96,382
Non-GAAP operating income
$
48,014
$
40,048
$
137,152
$
114,707
Non-GAAP operating margin
15.2
%
14.1
%
14.5
%
13.8
%
Non-GAAP Net Income
Three Months Ended
Nine Months Ended
March 31,
2026
March 31,
2025
March 31,
2026
March 31,
2025
GAAP net income
$
10,590
$
3,458
$
24,077
$
336
Adjustments:
Share-based compensation expense
21,768
20,354
66,447
61,573
Restructuring and related charges (benefit)
—
(441
)
538
1,871
Litigation charges
376
1,123
3,135
12,716
System transition costs
7,556
7,548
18,948
16,919
Amortization of intangibles
743
1,087
2,578
3,303
Other non-recurring costs
231
—
3,879
—
Debt refinancing charges
—
—
—
79
Tax effect of non-GAAP adjustments
(6,419
)
(5,171
)
(19,888
)
(17,866
)
Total non-GAAP adjustments to GAAP net income
$
24,255
$
24,500
$
75,637
$
78,595
Non-GAAP net income
$
34,845
$
27,958
$
99,714
$
78,931
Earnings per share
GAAP net income per share – diluted
$
0.08
$
0.03
$
0.18
$
0.00
Non-GAAP net income per share – diluted
$
0.26
$
0.21
$
0.74
$
0.59
Shares used in net income per share – diluted:
GAAP shares used in per share calculation – basic
132,931
132,979
133,275
132,173
Potentially dilutive equity awards
660
1,611
1,642
1,597
GAAP and Non-GAAP shares used in per share calculation – diluted
Extreme Networks (EXTR) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.24 per share. This compares to earnings of $0.21 per share a year ago.
Extreme Networks delivered a double beat in Q3 '26, with revenues up 11.2% to $316.9M and EPS of $0.26. SaaS ARR accelerated to 29% y/y, with Extreme Platform One adoption driving recurring revenues to 36% of total; EMEA revenue surged 43%. Gross margins remained stable at 61.7% GAAP, while operating margins improved; the Wi-Fi 7 refresh cycle and Platform One adoption are key forward growth drivers.
MORRISVILLE, N.C.--(BUSINESS WIRE)--Extreme Networks, Inc. (Nasdaq: EXTR), a leader in AI-powered automation for networking, today announced its investor conference schedule for May and June 2026:
Extreme Connect 2026
Ed Meyercord, President and CEO
Kevin Rhodes, EVP and CFO
Nabil Bukhari, EVP, Chief Technology Officer and President, AI Platforms
Orlando, FL
Monday, May 4 – Thursday, May 7, 2026
8:30 a.m. ET Watch Keynotes Live on Tuesday, May 5 and Wednesday, May 6
Conducting meetings throughout the week 21st Annual Needham Technology, Media, & Consumer 1x1 Conference
Stan Kovler, SVP, Finance and Corporate Development
New York, NY
Tuesday, May 12, 2026
12:45 p.m. ET Fireside chat and meetings throughout the day 54th Annual J.P. Morgan Global Technology, Media and Communications Conference
Ed Meyercord, President and CEO
Boston, MA
Monday, May 18, 2026
11:45 a.m. ET Fireside chat and meetings throughout the day B. Riley Securities 26th Annual Investor Conference
Kevin Rhodes, EVP and CFO
Marina del Rey, CA
Wednesday, May 20, 2026
Conducting meetings throughout the day Evercore Global TMT Conference
Kevin Rhodes, EVP and CFO
San Francisco, CA
Tuesday, June 2, 2026
Conducting meetings throughout the day Bank of America 2026 Global Technology Conference
Kevin Rhodes, EVP and CFO
San Francisco, CA
Wednesday, June 3, 2026
9:20 a.m. PT Fireside chat and meetings throughout the day Rosenblatt’s 6th Annual Technology Summit
Kevin Rhodes, EVP and CFO
Virtual
Wednesday, June 10, 2026
11:00 a.m. ET Fireside chat and meetings throughout the day A live webcast from each fireside chat will be accessible under Events & Presentations on the Investor Relations section of the Extreme Networks website at http://investor.extremenetworks.com and will be archived for at least 30 days following the live presentation.
About Extreme Networks:
Extreme Networks, Inc. (EXTR) is a leader in AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. We push the boundaries of technology, leveraging the powers of artificial intelligence, analytics, and automation. Tens of thousands of customers globally trust our AI-powered cloud networking solutions and industry-leading support to enable businesses to drive value, foster innovation, and overcome extreme challenges. For more information, visit Extreme's website at www.extremenetworks.com or follow us on LinkedIn, YouTube, X, Facebook, or Instagram.
Extreme Networks and the Extreme Networks logo are trademarks or registered trademarks of Extreme Networks, Inc. in the United States and other countries.
NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF continues its investigation into Extreme Networks, Inc. (NasdaqGS: EXTR).
On January 31, 2024, the Company disclosed disappointing financial results and operational trends for 2Q24 including, among other things, that its revenues for the quarter were $296.4 million, down 7% year-over-year, and that it generated just $186.6 million in product revenue, a decline of 37% year-over-year.
Thereafter, the Company and certain of its executives were sued in a securities class action lawsuit, charging them with failing to disclose material information during the Class Period in violation of federal securities laws. Specifically, the case alleges that Defendants made false and misleading statements about Extreme’s product revenue and backlog between July 27, 2022 and January 30, 2024. Recently, the Court presiding over the case denied the Company’s motion to dismiss the case, allowing the case to move forward.
KSF’s investigation is focusing on whether Extreme’s officers and/or directors breached their fiduciary duties to its shareholders or otherwise violated state or federal laws.
If you have information that would assist KSF in its investigation, or have been a long-term holder of Extreme shares and would like to discuss your legal rights, you may, without obligation or cost to you, call toll-free at 1-833-938-0905 or email KSF Managing Partner Lewis Kahn ([email protected]), or visit https://www.ksfcounsel.com/cases/nasdaqgs-extr/ to learn more.
About Kahn Swick & Foti, LLC
KSF, whose partners include former Louisiana Attorney General Charles C. Foti, Jr., is one of the nation's premier boutique securities litigation law firms. This past year, KSF was ranked by SCAS among the top 10 firms nationally based upon total settlement value. KSF serves a variety of clients, including public and private institutional investors, and retail investors - in seeking recoveries for investment losses emanating from corporate fraud or malfeasance by publicly traded companies. KSF has offices in New York, Delaware, California, Louisiana, Chicago, New Jersey, and a representative office in Luxembourg.
TOP 10 Plaintiff Law Firms - According to ISS Securities Class Action Services
To learn more about KSF, you may visit www.ksfcounsel.com.
Innovative operating model moves industry from assistive AI to autonomous, always-on operations
MORRISVILLE, N.C.--(BUSINESS WIRE)--Extreme Networks, Inc. (NASDAQ: EXTR) today introduced Extreme Agent ONE™, a new class of AI agents for enterprise networking. Moving beyond generic, prompt-based AI, Extreme Agent ONE runs on the Extreme AI stack purpose-built for enterprise environments, which combines advanced AI reasoning, live network context, and operational expertise to transform enterprise networks into systems that detect, decide, and act autonomously within the established governance framework. As a result, customers experience fewer disruptions, faster outcomes, and networks that operate at the speed of the business.
Nabil Bukhari, CTO and President of AI Platforms at Extreme Networks, said, “As networks begin to think, adapt, and act in real-time, the relationship between human users and AI agents will rapidly evolve, making simplicity and control essential to success. Our vision is autonomous networking at scale delivered on a foundation of trust between humans and AI agents, which means fewer disruptions, faster outcomes, and operational efficiency.”
Agent ONE Coworker: Proactive AI That Works Alongside IT Teams
The first mode of Extreme Agent ONE, available Q3 CY2026 within Extreme Platform ONE™, is Agent ONE Coworker, an AI agent designed to work alongside IT teams and deliver proactive, context-aware intelligence with real-time decisioning and automated execution at machine speed. Through a single conversational interface, it continuously monitors network activity, investigates anomalies, and acts, reducing resolution times, minimizing manual effort, and preventing issues before they impact users.
Unlike traditional AI tools that wait for prompts, Agent ONE Coworker operates proactively, surfacing insights and guiding decisions within the workflow. Its “Nudge” capability delivers timely, contextual recommendations that turn insight into immediate action.
For example, it can detect rising Wi-Fi congestion in a school and recommend or automatically apply a fix or identify recurring POS slowdowns in retail and suggest traffic prioritization during peak hours, turning patterns into immediate, low-effort decisions.
Agent ONE Coworker will deliver:
Conversational access to network data, documentation, and security insights Automated support workflows from case creation through resolution On-demand, real-time dashboards built from live data AI-driven Wi-Fi optimization through conversational control Proactive insights via “Nudge,” surfacing issues and recommendations based on urgency and context Agent ONE Operator: Always-On Autonomous Network Operations
Extreme also announced the second mode for Agent ONE, available Q4 CY2026, Agent ONE Operator, an always-on, autonomous agent designed to extend AI beyond real-time interaction to continuous network operation.
Agent ONE Operator will execute tasks independently within defined governance boundaries, responding to events in real time and running scheduled workflows without requiring constant human input. It will continuously learn from each interaction and outcome, becoming more precise and effective over time.
This evolution represents a shift from AI that assists in the moment to AI that operates continuously, ensuring networks are always monitored, optimized, and improving, even when IT teams are not actively engaged.
The Extreme AI Stack: Foundation for Autonomous Networking
The Extreme AI stack unifies data, intelligence, and automation into a continuously learning, closed-loop system—enabling real-time, autonomous execution across the network. Key capabilities include:
Advanced AI reasoning that continuously improves with leading models Real-time, environment-specific context across users, devices, and policies Encoded operational expertise, turning best practices into scalable, executable workflows Autonomous agents that analyze, validate, and act securely at scale, learning from users as the relationship between users and agents evolves “Most vendors are still delivering AI as copilots,” said Zeus Kerravala, founder of ZK Research. “Extreme is taking a different path—embedding reasoning, context, and execution into the network itself. That’s a meaningful step toward true autonomous infrastructure and a clear signal of where the industry is going.”
Extreme Exchange: Extending AI with Extensible Skills
Extreme also introduced Extreme Exchange™, an AI skills marketplace for Extreme Platform ONE that enables customers to discover, activate, and manage skills that extend Agent ONE Operator’s capabilities.
Extreme Exchange delivers domain-specific intelligence across industries such as healthcare, education, retail, and manufacturing, while integrating with IT service management, security, observability, and cloud platforms. Built on an open model, it supports first-party and partner-developed skills and is designed to support customer-created skills in the future.
About Extreme Networks
Extreme Networks, Inc. (EXTR) is a leader in AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. We push the boundaries of technology, leveraging the powers of artificial intelligence, analytics, and automation. Tens of thousands of customers globally trust our AI-driven cloud networking solutions and industry-leading support to enable businesses to drive value, foster innovation, and overcome extreme challenges.
For more information, visit Extreme's website at www.extremenetworks.com or follow us on LinkedIn, YouTube, X, Facebook, or Instagram.
Extreme Networks, Extreme Platform ONE, Extreme Agent ONE, Extreme Exchange, and the Extreme Networks logo are trademarks or registered trademarks of Extreme Networks, Inc. in the United States, and other countries. Other trademarks shown herein are the property of their respective owners.
New Wi-Fi 7 APs provide reliable, high-speed connectivity, from packed indoor venues to extreme outdoor environments
MORRISVILLE, N.C.--(BUSINESS WIRE)--Extreme Networks, Inc. (Nasdaq: EXTR), a leader in AI-powered automation for networking, has introduced several new Wi-Fi 7 solutions to deliver fast, secure connectivity for critical use cases including real-time AI workloads, AR/VR experiences, smart manufacturing, telehealth, and high-density venues. Organizations worldwide including Baylor University, Henry Ford Health, Six Flags, University Hospitals Birmingham NHS Foundation Trust, and multiple NFL teams already rely on Extreme’s Wi-Fi 7 solutions to power high-density connectivity, real-time applications, and next-generation digital experiences.
Extreme offers the industry’s most complete, deployment-ready Wi-Fi 7 portfolio, delivering Access Points (APs) that combine optimized performance with practical efficiency and support everything from demanding environments like hospitals and stadiums to cost-effective deployments in schools, retail, and hospitality. Easily managed through Extreme Platform ONE™, they deliver secure, reliable connectivity without the power tradeoffs common in competing solutions. Support for both low and standard power 6 GHz enables customers to benefit from Wi-Fi 7 performance gains without switch or power upgrades, delivering built-in compliance for global regulations.
The AP5060 series outdoor and AP5022 series indoor APs deliver premium performance with three 4x4 radios, a dedicated tri-band security sensor, and integrated IoT radios to support growing device demands. The AP5060 is engineered for harsh environments, combining a ruggedized design with the durability and resilience needed to deliver reliable, long-term connectivity in demanding settings such as hospitals, industrial facilities, and stadiums. Both series support flexible tri-band operation on standard PoE+ (802.3at), allowing customers to deploy broadly while choosing the right balance of radio performance, scanning, and functionality for each environment. The AP3020 series indoor and AP3060 weatherized outdoor series deliver full-feature Wi-Fi 7 at a competitive cost, with 2x2 radio designs optimized for space and power-constrained environments like schools, retail, and hospitality. The AP3020W features a low-profile wall plate design that balances aesthetics and functionality, making it a natural fit for hospitality, education, and multi-dwelling environments. The AP3020X includes support for external antennas, enabling more flexible designs for environments that benefit from directional Wi-Fi like high-density venues. The AP3060 is IP67-rated and offers a compact design with an extended temperature range, built to withstand harsh conditions from high winds to sub-zero temperatures. “Wi-Fi 7 adoption is accelerating as organizations scale IoT and real-time AI workloads. Extreme’s cloud-managed Wi-Fi 7 solutions combine high-performance hardware with intelligent management to simplify operations and keep networks ready for what’s next,” said Siân Morgan, Research Director at Dell’Oro Group.
“Our customers need reliable, high-speed Wi-Fi more than ever, especially as mobility, real-time applications, and device density continue to increase and we move further into the era of 6 GHz connectivity,” said David Coleman, Director of Wireless in the Office of the CTO at Extreme Networks. “These Wi-Fi 7 solutions will help customers meet those demands with stronger performance for modern AI-driven environments, improved power efficiency, and simpler deployment and operations at scale.”
About Extreme Networks
Extreme Networks, Inc. (EXTR) is a leader in AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. We push the boundaries of technology, leveraging the powers of artificial intelligence, analytics, and automation. Tens of thousands of customers globally trust our AI-driven cloud networking solutions and industry-leading support to enable businesses to drive value, foster innovation, and overcome extreme challenges.
For more information, visit Extreme's website at www.extremenetworks.com or follow us on LinkedIn, YouTube, X, Facebook, or Instagram.
Extreme Networks, Extreme Platform ONE, and the Extreme Networks logo are trademarks or registered trademarks of Extreme Networks, Inc. in the United States, and other countries. Other trademarks shown herein are the property of their respective owners.
Autonomous AI meets integrated security, simple pricing, and third-party management to power the next era of networking
MORRISVILLE, N.C.--(BUSINESS WIRE)--Extreme Networks, Inc. (Nasdaq: EXTR) today announced major advancements to Extreme Platform ONE™ including expanded third-party device management and integrated security, delivering a more intelligent, scalable, and secure enterprise networking solution. The platform is further enhanced with the introduction of Extreme Agent ONE™, a new class of AI agents for enterprise networking.
"Enterprise IT organizations are moving past fragmented tools and experimental AI deployments; they're demanding platforms that deliver integrated, automated operations at scale,” said Brandon Butler, Senior Research Manager, Network Infrastructure and Services at IDC. “A unified architecture that ties agentic AI, security, and multi-vendor management into a single operating model is a meaningful response to that demand. Advanced networking platforms are fast becoming a prerequisite for enterprises serious about turning AI investment into real outcomes, and vendors that deliver it are squarely aligned with where IT buyers are heading."
Extreme Platform ONE, generally available as of July 2025, was the industry’s first all-in-one AI-powered networking platform. With the latest set of advancements and new features, Extreme Platform ONE, in combination with Extreme Agent ONE and Extreme’s AI stack, delivers the foundation for a new generation of adaptive, intelligent networks.
Third-Party Management: Across Multi-Vendor Networks, from Cloud to On-Prem
Extreme Platform ONE now supports third-party hardware from other networking vendors, enabling customers to discover, monitor, and manage third-party devices within the platform, reducing tool sprawl, complexity, and costs while allowing customers switching to Extreme to migrate at their own pace without disrupting existing environments. Extreme’s edge service within Extreme Platform ONE extends platform reach securely from cloud to on-prem, offloading configuration and policy enforcement through a single platform.
Extreme Platform ONE Security: Zero Trust Without Complexity
Extreme Platform ONE Security now unifies network and security workflows in a single, intuitive experience, ensuring consistent policy enforcement, streamlined operations, and fewer authentication issues. With the addition of built-in Cloud PKI capabilities such as certificate authority, lifecycle management, deployment, and renewal, the platform enables identity-based Zero Trust security, continuously authenticating users, devices, and applications, while integrating with leading identity providers (IdP) and mobile device management (MDM) platforms. Combined with automated policy enforcement and certificate lifecycle management, organizations gain stronger security, reduced overhead, and end-to-end visibility without added complexity.
Extreme Platform ONE Enterprise Agreement: Simplifying Commercial Terms
The Extreme Platform ONE Enterprise Agreement simplifies how large customers buy, manage, and expand platform adoption. A single, consolidated agreement simplifies procurement, with co-termed subscriptions and price protection delivering predictable costs and easier renewals. This new approach removes long-standing friction in enterprise networking, enabling seamless expansion, self-service management, and significantly lower operational overhead.
Additional New Features
Extreme Platform ONE now also includes additional capabilities that further extend the platform's value at no extra cost:
Secure, flexible Wi-Fi guest access with multiple visitor onboarding options and built-in engagement analytics. Real-time asset, employee, and visitor tracking with floor-level location resolution and behavioral analytics. Wireless Intrusion Prevention System (WIPS) delivers centralized sensor management and security threat scoring across all locations. “Extreme is redefining the networking industry – we were the first to introduce an all-in-one AI-powered networking platform, and today we are continuing to reimagine what networks can do,” said Nabil Bukhari, CTO and President of AI Platforms at Extreme Networks. “With Extreme Platform ONE, we’re enabling enterprises to move from static infrastructure to intelligent, autonomous systems that drive the business forward. With these new features, the network isn’t just supporting operations, but actively accelerating innovation, resilience, and growth.”
About Extreme Networks
Extreme Networks, Inc. (EXTR) is a leader in AI-powered cloud networking, focused on delivering simple and secure solutions that help businesses address challenges and enable connections among devices, applications, and users. We push the boundaries of technology, leveraging the powers of artificial intelligence, analytics, and automation. Tens of thousands of customers globally trust our AI-driven cloud networking solutions and industry-leading support to enable businesses to drive value, foster innovation, and overcome extreme challenges. For more information, visit Extreme's website at www.extremenetworks.com or follow us on LinkedIn, YouTube, X, Facebook, or Instagram.
Extreme Networks, Extreme Platform ONE, Extreme Agent ONE, and the Extreme Networks logo are trademarks or registered trademarks of Extreme Networks, Inc. in the United States, and other countries. Other trademarks shown herein are the property of their respective owners.
Shareholders are urged to contact the firm immediately at no cost or obligation, as there may be limited time to enforce your rights.
We would handle the matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.
, /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Extreme Networks, Inc. (NASDAQ: EXTR) breached their fiduciary duties to shareholders.
If you currently own Extreme Networks stock and are a long-term shareholder, you may be able to seek corporate governance reforms, the return of funds back to the company, a court-approved financial incentive award, or other relief and benefits. Please click here to learn more about your legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or [email protected] or [email protected].
Why Your Participation Matters:
Shareholder involvement can help improve a company's policies, practices, and oversight mechanisms to create a more transparent, accountable, and effectively managed organization, which can enhance shareholder value.
Halper Sadeh LLC represents investors all over the world who have fallen victim to securities fraud and corporate misconduct. Our attorneys have been instrumental in implementing corporate reforms and recovering millions of dollars on behalf of defrauded investors.
Attorney Advertising. Prior results do not guarantee a similar outcome.
Contact Information:
Halper Sadeh LLC
One World Trade Center
85th Floor
New York, NY 10007
Daniel Sadeh, Esq.
Zachary Halper, Esq.
(212) 763-0060
[email protected]
[email protected]
https://www.halpersadeh.com
Ciena Stock: Powering the AI Boom - A Network Infrastructure PlayExtreme Networks NASDAQ: EXTR is positioning its AI-driven networking platform as a central part of its push into larger enterprise and government accounts, Chief Executive Officer Ed Meyercord said during a JPMorgan fireside chat hosted by analyst Samik Chatterjee.
Meyercord said the company recently used a user conference in Orlando to announce its second-generation AI platform, following the initial Platform ONE launch in July. The update includes Agent ONE, which he described as an “agentic” platform that can function as a coworker for IT networking teams by handling tasks such as troubleshooting and firmware upgrades under customer control.
Get Extreme Networks alerts:
Arista Networks Advances the Era of AI and Microperimeters The company also announced an operator mode, or agent exchange, which Meyercord said would allow customers and partners to build workflows and tools alongside Extreme. He pointed to Kroger, Korean Air and other customers as examples of enterprises that want to integrate their own development work with Extreme’s network platform.
“The big part of the evolution for Extreme” is moving beyond a license tied to a networking device and toward a platform where the company co-develops with customers and partners, Meyercord said. Agent ONE is expected to be released in July, while the exchange capability is expected to reach general availability in the October timeframe, he said.
AI Seen as a Driver of Enterprise Network Investment Extreme Networks Snags an Upgrade on Inventory NormalizationMeyercord said customer conversations around AI have changed significantly over the past year. At the company’s user conference a year ago, he said customers were skeptical about whether AI would affect networking. This year, he said the discussion shifted toward how quickly AI use cases could be deployed and where customers are in their adoption journeys.
Asked about network refresh activity tied to AI, Meyercord said the industry is benefiting from broader refresh cycles, including Cisco’s announced multiyear network refresh as its Catalyst platform reaches end of life. He said that dynamic gives Extreme more opportunities to compete as customers evaluate alternatives.
He also said agent traffic is expected to develop on enterprise networks, while frontier and reasoning models remain in hyperscale cloud environments. However, he cautioned that it remains difficult to quantify the impact.
“We all know it’s coming,” Meyercord said, adding that enterprise customers are actively exploring AI and agentic AI use cases but do not yet have a full understanding of what that will mean for network traffic.
Large Customer Wins Support Growth Outlook Chatterjee asked about the company’s stated target of a 10% revenue compound annual growth rate through fiscal 2029. Meyercord said Extreme’s confidence is tied to its move upmarket and the types of customers it is winning.
He cited the government of Japan as a major example, calling it the company’s largest project to date in Asia-Pacific. Meyercord said the project began at about $40 million and could be closer to $80 million in network investment when complete. He said Extreme won after entering the process as a fourth participant, citing its campus fabric technology, use of fabric across the wide area network, private cloud capabilities and network segmentation features.
Meyercord also said the win has helped Extreme develop relationships with larger ecosystem partners in Japan, including NTT East, KDDI and Net One Systems. He described those channel relationships as important because partners deploy the technology and bring additional opportunities.
Other large customers discussed included Kroger and Korean Air. Meyercord said Korean Air’s network transformation project is expected to last nine years, underscoring the long-term nature of some networking deployments.
Memory Supply Positioned as Potential Advantage Meyercord said Extreme has addressed memory supply risks through calendar 2027 and could benefit if competitors face longer lead times. He said the company reorganized its supply relationships, including working with Micron through Avnet, qualifying Samsung chips for its platforms with help from Broadcom, and sourcing chips originally intended for other industrial segments such as automotive.
He said Broadcom treated Extreme as a strategic partner during the shortage and helped the company identify additional vendors and qualify alternative components. While Meyercord said the company has not included a competitive supply benefit in its forecasts, he said stretched lead times elsewhere could create opportunities for Extreme on time-sensitive projects.
Wi-Fi 7 Adoption and Recurring Revenue Meyercord said Wi-Fi 7 now accounts for roughly half of Extreme’s wireless booking dollars. He said he does not necessarily view Wi-Fi 7 alone as a trigger for faster network refreshes, but said the technology is important because customers increasingly view it as capable of supporting mission-critical applications.
He noted that Extreme introduced Wi-Fi 7 at the end of December 2023 and said the University of Florida’s football stadium, The Swamp, will be the first college stadium with Wi-Fi 7.
On recurring revenue, Meyercord said recurring revenue recently represented 36% of total revenue, while subscription revenue tied to Platform ONE adoption rose 29% year over year. He said the company is combining services and subscriptions in Platform ONE, which should become more visible in fiscal 2027 and especially fiscal 2028.
Meyercord said recurring revenue should rise above 40% over the next few years, driven by Platform ONE subscription growth. He also said service revenue combined with subscription revenue can produce a 10% to 15% uplift.
Extreme has several thousand customers on Platform ONE, Meyercord said. He said the platform combines nine systems into one and should soon be able to support about 80% of customers’ needs. By the end of next year, he said the company expects roughly 70% of customers to be fully on Platform ONE.
Execution Focus Remains on Larger Channels Asked about execution risks over the next three to five years, Meyercord said Extreme’s main challenge is gaining more attention as it moves upmarket through larger channel partners. He cited Cisco as a strong competitor with established channel relationships, strong marketing and significant capital.
For Extreme, Meyercord said the focus is on building brand recognition, securing more competitive opportunities and expanding with larger channel partners.
About Extreme Networks NASDAQ: EXTRExtreme Networks, Inc NASDAQ: EXTR is a global provider of end-to-end networking solutions designed to support enterprise, data center, and service provider environments. The company's product portfolio encompasses high-performance wired and wireless access switches, routers, network security appliances, and software-defined networking (SDN) tools. Driven by a cloud-native management architecture, Extreme's Intelligent Edge Platform integrates network analytics, automation and orchestration capabilities to help organizations optimize performance, reduce operational complexity and strengthen security.
Since its founding in the mid-1990s and subsequent public listing in 1999, Extreme Networks has expanded its technology footprint through targeted acquisitions.
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].
Should You Invest $1,000 in Extreme Networks Right Now?Before you consider Extreme Networks, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Extreme Networks wasn't on the list.
While Extreme Networks currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.
After reaching an important support level, Extreme Networks, Inc. (EXTR - Free Report) could be a good stock pick from a technical perspective. EXTR recently experienced a "golden cross" event, which saw its 50-day simple moving average breaking out above its 200-day simple moving average.
There's a reason traders love a golden cross -- it's a technical chart pattern that can indicate a bullish breakout is on the horizon. This kind of crossover is formed when a stock's short-term moving average breaks above a longer-term moving average. Typically, a golden cross involves the 50-day and the 200-day moving averages, since bigger time periods tend to form stronger breakouts.
Golden crosses have three key stages that investors look out for. It starts with a downtrend in a stock's price that eventually bottoms out, followed by the stock's shorter moving average crossing over its longer moving average and triggering a trend reversal. The final stage is when a stock continues the upward climb to higher prices.
This kind of chart pattern is the opposite of a death cross, which is a technical event that suggests future bearish price movement.
Shares of EXTR have been moving higher over the past four weeks, up 31.8%. Plus, the company is currently a #2 (Buy) on the Zacks Rank, suggesting that EXTR could be poised for a breakout.
Once investors consider EXTR's positive earnings outlook for the current quarter, the bullish case only solidifies. No earnings estimate has gone lower in the past two months compared to 3 revisions higher, and the Zacks Consensus Estimate has increased as well.
Investors may want to watch EXTR for more gains in the near future given the company's key technical level and positive earnings estimate revisions.
Shares of Resideo Technologies, Inc. (NYSE:REZI – Get Free Report) have been given an average rating of “Hold” by the five research firms that are currently covering the stock, Marketbeat reports. One research analyst has rated the stock with a sell recommendation, two have issued a hold recommendation and two have given a buy recommendation to the company. The average twelve-month price target among brokerages that have issued a report on the stock in the last year is $39.6667.
Several research analysts have recently commented on the company. Oppenheimer reissued an “outperform” rating on shares of Resideo Technologies in a report on Friday, March 13th. Weiss Ratings reissued a “sell (d+)” rating on shares of Resideo Technologies in a report on Thursday, January 22nd. Finally, Morgan Stanley boosted their price objective on Resideo Technologies from $42.00 to $50.00 and gave the stock an “overweight” rating in a report on Wednesday, February 25th.
Get Our Latest Research Report on REZI
Resideo Technologies Stock Up 0.7% Shares of NYSE REZI opened at $34.88 on Tuesday. Resideo Technologies has a 12 month low of $14.18 and a 12 month high of $45.29. The company has a current ratio of 1.91, a quick ratio of 1.14 and a debt-to-equity ratio of 1.30. The firm has a market capitalization of $5.27 billion, a price-to-earnings ratio of -8.65 and a beta of 1.70. The business has a 50-day moving average of $35.34 and a 200-day moving average of $36.59.
Institutional Trading of Resideo Technologies Hedge funds have recently bought and sold shares of the company. Russell Investments Group Ltd. lifted its position in Resideo Technologies by 108.3% in the 2nd quarter. Russell Investments Group Ltd. now owns 140,886 shares of the company’s stock worth $3,108,000 after buying an additional 73,261 shares during the last quarter. Universal Beteiligungs und Servicegesellschaft mbH lifted its position in Resideo Technologies by 274.7% in the 3rd quarter. Universal Beteiligungs und Servicegesellschaft mbH now owns 83,892 shares of the company’s stock worth $3,622,000 after buying an additional 61,504 shares during the last quarter. Clayton Dubilier & Rice LLC lifted its position in Resideo Technologies by 130.3% in the 3rd quarter. Clayton Dubilier & Rice LLC now owns 13,286,384 shares of the company’s stock worth $573,706,000 after buying an additional 7,516,233 shares during the last quarter. Alpha Wave Global LP bought a new stake in Resideo Technologies in the 3rd quarter worth approximately $8,811,000. Finally, Hudson Bay Capital Management LP bought a new stake in Resideo Technologies in the 3rd quarter worth approximately $3,022,000. Institutional investors own 91.71% of the company’s stock.
About Resideo Technologies (Get Free Report)
Resideo Technologies, Inc, headquartered in Austin, Texas, is a global provider of home comfort, security and energy management solutions. Formed as an independent company in 2018 following its spin-off from Honeywell, Resideo leverages decades of engineering experience to deliver connected products and services to residential and light commercial customers.
The company’s core offerings include smart thermostats, security systems, video doorbells, water leak and freeze detection devices, and indoor air quality monitors.
Recommended Stories Five stocks we like better than Resideo Technologies
Receive News & Ratings for Resideo Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Resideo Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINEBicycle Therapeutics (NASDAQ:BCYC) CEO Kevin Lee Sells 5,967 Shares
NEXT HEADLINE »Huron Consulting Group (NASDAQ:HURN) Director Debra Zumwalt Sells 170 Shares of Stock
Life360 (NASDAQ:LIF – Get Free Report) and Resideo Technologies (NYSE:REZI – Get Free Report) are both mid-cap industrials companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, earnings, dividends, analyst recommendations and institutional ownership.
Analyst Ratings This is a breakdown of current recommendations for Life360 and Resideo Technologies, as provided by MarketBeat.
Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Life360 0 5 5 0 2.50 Resideo Technologies 1 2 2 0 2.20 Life360 presently has a consensus target price of $75.16, indicating a potential upside of 97.28%. Resideo Technologies has a consensus target price of $39.67, indicating a potential upside of 5.31%. Given Life360’s stronger consensus rating and higher probable upside, analysts clearly believe Life360 is more favorable than Resideo Technologies.
Insider & Institutional Ownership 20.0% of Life360 shares are held by institutional investors. Comparatively, 91.7% of Resideo Technologies shares are held by institutional investors. 1.5% of Resideo Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Earnings and Valuation This table compares Life360 and Resideo Technologies”s revenue, earnings per share and valuation.
Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Life360 $489.48 million 6.24 $150.83 million $1.75 21.77 Resideo Technologies $7.47 billion 0.76 -$527.00 million ($4.03) -9.35 Life360 has higher earnings, but lower revenue than Resideo Technologies. Resideo Technologies is trading at a lower price-to-earnings ratio than Life360, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility Life360 has a beta of 3.9, suggesting that its stock price is 290% more volatile than the S&P 500. Comparatively, Resideo Technologies has a beta of 1.7, suggesting that its stock price is 70% more volatile than the S&P 500.
Profitability This table compares Life360 and Resideo Technologies’ net margins, return on equity and return on assets.
Net Margins Return on Equity Return on Assets Life360 30.82% 7.81% 4.44% Resideo Technologies -7.27% 15.15% 4.43% Summary Life360 beats Resideo Technologies on 10 of the 14 factors compared between the two stocks.
About Life360 (Get Free Report)
Life360 Inc. is a family connection and safety company. Its business category includes mobile app and Tile tracking devices with a range of services, including location sharing, safe driver reports and crash detection with emergency dispatch. Life360 Inc. is based in SAN FRANCISCO.
About Resideo Technologies (Get Free Report)
Resideo Technologies, Inc. develops, manufactures, and sells comfort, energy management, and safety and security solutions to the commercial and residential end markets in the United States, Europe, and internationally. The company operates in two segments, Products and Solutions, and ADI Global Distribution. The Products and Solutions segment provides temperature and humidity control, thermal and combustion solutions, water and indoor air quality solutions, energy products and solutions, water and air solutions, smoke and carbon monoxide detection home safety and fire suppression, security panels, sensors, peripherals, wire and cable, communications devices, video cameras, other home-related lifestyle convenience solutions, cloud infrastructure, installation and maintenance tools, and related software products under the Honeywell Home brand as well as Resideo, Braukmann, First Alert, and BRK brands. The ADI Global Distribution segment engages in the distribution of security, fire, access control, and video products; and participates in the broader related markets of smart home, power, audio, ProAV, networking, communications, data communications, wire and cable, enterprise connectivity, and structured wiring products. The company sells its products and services through a network of professional contractors, distributors, and original equipment manufacturers, as well as retail and online merchants. Resideo Technologies, Inc. was incorporated in 2018 and is headquartered in Scottsdale, Arizona.
Receive News & Ratings for Life360 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Life360 and related companies with MarketBeat.com's FREE daily email newsletter.
« PREVIOUS HEADLINECritical Comparison: National Vision (NASDAQ:EYE) and Grocery Outlet (NASDAQ:GO)
NEXT HEADLINE »Reviewing Focus Universal (FCUV) and Its Peers
, /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets, will release first quarter 2026 financial results after the close of the New York Stock Exchange on Tuesday, May 12, 2026. A webcast to discuss the results will be held on Tuesday, May 12, 2026 at 5:00 p.m. EDT.
Resideo is a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets. We are a leader in the home heating, ventilation, and air conditioning controls markets, smoke and carbon monoxide detection home safety and fire suppression products markets, and security products markets. Our solutions and services can be found in over 150 million residential and commercial spaces globally, with tens of millions new devices sold annually. For more information about Resideo and our trusted, well-established brands including First Alert, Honeywell Home, BRK, Control4, and others, visit www.resideo.com.
Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and waiting long for them to recover. Instead, they believe that "buying high and selling higher" is the way to make far more money in lesser time.
Who doesn't like betting on fast-moving trending stocks? But determining the right entry point isn't easy. Often, these stocks lose momentum once their valuation moves ahead of their future growth potential. In such a situation, investors find themselves loaded up on expensive shares with limited to no upside or even a downside. So, going all-in on momentum could be risky at times.
A safer approach could be investing in bargain stocks with recent price momentum. While the Zacks Momentum Style Score (part of the Zacks Style Scores system) helps identify great momentum stocks by paying close attention to trends in a stock's price or earnings, our 'Fast-Paced Momentum at a Bargain' screen comes handy in spotting fast-moving stocks that are still attractively priced.
Resideo Technologies (REZI - Free Report) is one of the several great candidates that made it through the screen. While there are numerous reasons why this stock is a great choice, here are the most vital ones:
Investors' growing interest in a stock is reflected in its recent price increase. A price change of 14.4% over the past four weeks positions the stock of this residential comfort and security systems maker well in this regard.
While any stock can see a spike in price for a short period, it takes a real momentum player to deliver positive returns for a longer time frame. REZI meets this criterion too, as the stock gained 19.1% over the past 12 weeks.
Moreover, the momentum for REZI is fast paced, as the stock currently has a beta of 1.7. This indicates that the stock moves 70% higher than the market in either direction.
Given this price performance, it is no surprise that REZI has a Momentum Score of B, which indicates that this is the right time to enter the stock to take advantage of the momentum with the highest probability of success.
In addition to a favorable Momentum Score, an upward trend in earnings estimate revisions has helped REZI earn a Zacks Rank #2 (Buy). Our research shows that the momentum-effect is quite strong among Zacks Rank #1 and #2 stocks. That's because as covering analysts raise their earnings estimates for a stock, more and more investors take an interest in it, helping its price race to keep up. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>
Most importantly, despite possessing fast-paced momentum features, REZI is trading at a reasonable valuation. In terms of Price-to-Sales ratio, which is considered as one of the best valuation metrics, the stock looks quite cheap now. REZI is currently trading at 0.82 times its sales. In other words, investors need to pay only 82 cents for each dollar of sales.
So, REZI appears to have plenty of room to run, and that too at a fast pace.
In addition to REZI, there are several other stocks that currently pass through our 'Fast-Paced Momentum at a Bargain' screen. You may consider investing in them and start looking for the newest stocks that fit these criteria.
This is not the only screen that could help you find your next winning stock pick. Based on your personal investing style, you may choose from over 45 Zacks Premium Screens that are strategically created to beat the market.
However, keep in mind that the key to a successful stock-picking strategy is to ensure that it produced profitable results in the past. You could easily do that with the help of the Zacks Research Wizard. In addition to allowing you to backtest the effectiveness of your strategy, the program comes loaded with some of our most successful stock-picking strategies.
Click here to sign up for a free trial to the Research Wizard today.
The Zacks Security and Safety Services industry is poised to gain from the solid demand for products and solutions, driven by the growing awareness about the security and safety of people and infrastructure. Increased efforts on research and development, backed by government support, augur well for the industry’s near-term prospects.
Growing demand for cybersecurity products is also benefiting many participants within the industry. Companies like Resideo Technologies, Inc. (REZI - Free Report) , ADT Inc. (ADT - Free Report) , Life360, Inc. (LIF - Free Report) and Intellicheck, Inc. (IDN - Free Report) are a few industry participants that are expected to capitalize on the opportunities.
Industry Description The Zacks Security and Safety Services industry comprises firms that provide sophisticated and interactive security solutions and related services, which are meant to be used for residential, commercial and institutional purposes. A few industry players develop electrical weapons for personal defense and military, federal, law enforcement and private security. Some of the companies provide solutions for the recovery of stolen vehicles, wireless communication devices, equipment for the safety of facility infrastructure and employees, and products for detecting hazards. A few players provide a variety of services to automobile owners and insurance companies. The industry serves customers from various end markets, including manufacturing, electronics, hospitality, education, construction, telecommunications, aerospace and medical.
3 Security & Safety Services Industry Trends in Focus Healthy Demand for Security and Safety Services: Growing instances of terrorism and criminal activities, coupled with concerns related to the ever-increasing fraudulent activities, are driving demand for security and safety services. To improve the safety and surveillance of people or assets, governments, commercial operations, communities and other establishments across the world are rapidly deploying IP-based cameras. This is acting as a key growth driver for the industry. With growing urbanization, the increasing requirement to ensure the safety and security of infrastructure at offices, factories and residential buildings is aiding industry participants. Also, with rising instances of hacking, the industry is seeing higher demand for Internet security products and services like firewalls, intrusion detection systems and intrusion prevention systems. The increasing adoption of Artificial Intelligence (AI) is making fraudulent activities more sophisticated while simultaneously driving higher demand for security and safety services. People’s preference for purchasing products through e-commerce platforms has also opened up opportunities for industry players.
Other Favorable Trends: Increases in budgets and funds from governments have invited several big players to make significant investments in the research and development of advanced products and services. Government and law enforcement agencies in the United States and Canada are directly working with industry participants to strengthen the security infrastructure of smart cities. This has been helping the industry players to come up with enhanced products and solutions, thereby catering to the needs of customers.
High Debt Levels: Industry participants constantly focus on innovation, product upgrades and the development of new products to cater to the changing customer needs and stay competitive, making steady investments necessary. While this augurs well for the industry’s long-term growth, hefty investments in research and development often leave companies with highly leveraged balance sheets. The industry’s long-term debt/capital ratio is currently 0.60, higher than 0.27 of the Zacks S&P 500 composite index.
Zacks Industry Rank Indicates Bright Prospects The Zacks Security and Safety Services industry, housed within the broader Industrial Products sector, currently carries a Zacks Industry Rank #66. This rank places it in the top 27% of 244 Zacks industries.
The group’s Zacks Industry Rank, which is the average of the Zacks Rank of all the member stocks, indicates robust near-term prospects. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than two to one.
The industry’s positioning in the top 50% of the Zacks-Ranked industries is a result of the solid earnings outlook for the constituent companies in aggregate. Looking at the aggregate earnings estimate revisions, it appears that analysts are putting more faith in this group's earnings growth potential. The industry’s earnings estimates for 2026 have increased 13.7% over the past year.
We will present a few stocks from the industry that you may want to consider for your portfolio. But before that, it is worth taking a look at the industry’s shareholder returns and its current valuation first.
Industry Underperforms Sector & S&P 500 The Zacks Security and Safety Services industry has underperformed both the broader Industrial Products sector and the S&P 500 composite index in the past year.
Over this period, the industry has moved up 2.6% compared with the S&P 500 Index’s increase of 33.2% and the sector’s growth of 36.4%.
One-Year Price Performance
Industry's Current Valuation On the basis of forward P/E (F12M), which is a commonly used multiple for valuing security and safety services stocks, the industry is currently trading at 13.23X compared with the S&P 500’s and the sector’s 22.08X and 22.39X, respectively.
Over the past five years, the industry has traded as high as 21.79X, as low as 12.78X and at the median of 16.94X, as the chart below shows:
Price-to-Earnings Ratio vs SP500
Price-to-Earnings Ratio vs Sector
4 Security and Safety Services Stocks Leading the Pack Intellicheck: Based in Melville, NY, it is a leading technology company, developing and marketing wireless technology and identity systems for various applications, including mobile and handheld wireless devices for the government, military and commercial markets. IDN is benefiting from its market diversification strategy, strong customer base and growth in demand for its identity verification technology. Also, an increase in SaaS (Software as a Service) revenues, which consists of software licensed on a subscription basis, bodes well for the company.
In the past 30 days, estimates for this Zacks Rank #1 (Strong Buy) company’s earnings have remained steady for 2026. Shares of Intellicheck have skyrocketed 132.7% in the past year. You can see the complete list of today’s Zacks #1 Rank stocks here.
Price and Consensus: IDN
ADT: Based in Boca Raton, FL, the company offers security and smart home solutions, including smart security cameras, burglar & life safety alarms and smart home automation systems to residential customers and small businesses. ADT is gaining from strength in the Monitoring and related services (M&S) business, driven by an increase in average prices. Also, the company’s strategic initiatives, innovation and operational excellence bode well.
The Zacks Consensus Estimate for ADT’s 2026 earnings has remained steady in the past 30 days. Though shares of this Zacks Rank #2 (Buy) company have declined 7.7% in a year, the same increased 9.5% in the past month.
Price and Consensus: ADT
Resideo Technologies: Based in Scottsdale, AZ, REZI is engaged in producing and offering home comfort, safety and security, and energy management products under brands including Resideo, Braukmann and First Alert. Resideo Technologies is gaining from price realization in the OEM channel and strong demand for products in the electrical distribution and retail channels. Also, continued focus on product development and innovation bodes well for the company.
The Zacks Consensus Estimate for Resideo Technologies’ 2026 earnings has remained steady in the past 30 days. Shares of this Zacks Rank #2 company have surged 149.9% in the past year.
Price and Consensus: REZI
Life360: Based in San Mateo, CA, the company is engaged in offering location tracking, safety features and emergency services through its app. It also offers tile hardware devices to track lost items. The company is poised to gain from growth in subscribers, driven by improved retention rate and an increased number of monthly active users (MAU). Also, Life360’s investments in new business strategies bode well.
The Zacks Consensus Estimate for LIF’s 2026 earnings is pegged at $1.03 per share, indicating growth of 77.6% from the prior year. This Zacks Rank #2 stock has increased 9.2% in the past year.
Names ADI and Resideo Leadership Teams and Boards of Directors
Investor Days Scheduled for Mid-July to Provide Details on Resideo and ADI's Go-Forward Business and Value Creation Strategies
Spin-Off on Track for Completion Between Mid-Third Quarter and Mid-Fourth Quarter 2026
, /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI) ("Resideo" or the "Company"), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets, today provided an update on its planned spin-off of its ADI Global Distribution business ("ADI"), including:
Filing of the Form 10 registration statement (the "Form 10") with the U.S. Securities and Exchange Commission ("SEC"), a copy of which is available on the SEC website as well as Resideo's Investor Relations website; Announcing ADI's leadership team and Board of Directors; Announcing Resideo's leadership team and Board of Directors; Timing for Resideo and ADI Investor Day events in mid-July 2026; and Expected timing for completion of the spin-off between mid-third quarter and mid-fourth quarter of 2026. "Today's filing reflects the tremendous progress we have made to launch two industry-leading companies, each extremely well positioned to better serve customers and unlock shareholder value," said Jay Geldmacher, President and CEO of Resideo. "ADI's new leadership team and Board are a highly skilled and diverse group of individuals who will bring deep knowledge of ADI, cross-sector expertise and proven leadership that will help shape ADI's future. Similarly, we have a strong bench of talent at Resideo that will remain in place and lead the company forward following the separation."
Highlights from Form 10, ADI Leadership Team and Board of Directors
The Form 10 highlights how ADI will:
Leverage its preeminent platform position as a global specialty distributor of professionally installed low-voltage products servicing the commercial and residential markets through a leading omnichannel go-to-market platform. Deliver on its distinct value proposition with over 500,000 products from more than 1,000 suppliers, curated through disciplined category management and reinforced by long-standing relationships with top suppliers and premier integrators, high product availability and superior technical sales support. Drive sustained profitable growth and disciplined capital allocation to fund high-return investments and enable a balanced capital allocation approach that will initially be focused on deleveraging. Expand upon its strong financial foundation. In fiscal year 2025, ADI on a carveout basis generated revenue of approximately $4.8 billion, $261 million net loss, $318 million in Adjusted EBITDA, 22.3% gross margin profit, 5.5% net loss margin, and 6.6% Adjusted EBITDA margin.1 The ADI leadership team will include the following individuals:
Robert Aarnes, President and Chief Executive Officer. Mr. Aarnes has served as President of ADI at Resideo since 2018. Michael Carlet, Chief Financial Officer. Mr. Carlet has served as the Chief Financial Officer of Resideo since 2024 and previously served as the Chief Financial Officer of Snap One, which was acquired by Resideo in 2024. Marco Cardazzi, Chief Merchandising Officer. Mr. Cardazzi has been with ADI since 2011 and currently serves as Chief Merchandising Officer and previously served as Chief Marketing Officer, Vice President of Global Marketing and held various leadership roles across merchandising, marketing, category management and products. Alicia Copeland, Chief Operating Officer. Ms. Copeland has been with ADI since 2016, currently serving as Chief Operating Officer and previously as Chief Commercial Officer, Chief Transformation Officer, and Vice President of Global Operations. Jeannine Lane, General Counsel, Corporate Secretary and Chief Compliance Officer. Ms. Lane has served as the General Counsel and Corporate Secretary of Resideo since 2018 and previously held various senior positions within Honeywell's legal department. James Olender, Chief Information Officer. Mr. Olender joined ADI in 2026 as Chief Information Officer and previously held various executive roles within GE, including as Chief Information Officer of GE Vernova's Wind Segment, among others. Nicole Stevens, Chief Accounting Officer. Ms. Stevens joined ADI in 2026 as Senior Vice President of Accounting, and previously served as SVP Financial Reporting at Amwins, Vice President of Financial Reporting at Snap One (prior to Resideo's acquisition) and at EY. The ADI Board will be comprised of the following individuals:
Michael Kaufmann will serve as Chairman. Mr. Kaufmann previously served in numerous executive positions at Cardinal Health, including Chief Executive Officer and Chief Financial Officer, among others. He is a seasoned board member and currently serves on the board of MSC Industrial Direct. Robert Aarnes will serve as a director, in addition to his role as President and Chief Executive Officer of ADI. William Galvin has over 35 years of experience as a senior executive and leader in the industrial distribution and supply chain services sector. Mr. Galvin was most recently President and CEO of Anixter International, a global distributor of network and security, electrical and electronic and utility power solutions. He currently serves on the boards of Integrated Power Services and Engineered & Industrial Solutions. Mr. Galvin is an operating advisor of CD&R. Christine Gorjanc is a financial expert who has served as Chief Financial Officer for various companies, including Invitae, Arlo Technologies and NETGEAR. She has held numerous public company board director roles, including as Audit Committee Chair, and currently serves on the boards of Polestar Automotive and Forward Air Corporation. Cynthia Hostetler has 26 years of leadership experience managing large investment funds (with significant global markets investments), guiding institutional investors and allocating capital resources for businesses. She is an experienced board member and currently serves on several mutual fund boards, including as trustee of Invesco Funds, director of TriLinc Global Impact Fund and board member of Investment Company Institute. Ms. Hostetler has served as a director on the Resideo board since 2020 and effective upon the spin-off, she will resign from the Resideo board. Stephen O. LeClair has decades of experience within the specialty distribution industry, including senior executive roles across operations, manufacturing, finance and sales. Mr. LeClair served as Executive Chair and Chief Executive Officer of Core & Main and previously held senior operations roles at HD Supply Waterworks, HD Supply Lumber and Building Materials, HD Supply and within GE Equipment Services. Mr. LeClair currently serves on the boards of Dycom Industries and AAON. Nathan Sleeper is the Chief Executive Officer of CD&R and chairs the investment firm's executive committee and is a member of its investment, operating review and compliance committees. Mr. Sleeper has served on numerous public company boards and is currently a member of the Columbus McKinnon Corporation board. Mr. Sleeper has served as a director on the Resideo board since 2024 and effective upon the spin-off, he will resign from the Resideo board. Brian Walker has extensive experience in the distribution sector and currently serves as Senior Vice President, Sales and Onsite Services of W.W. Grainger and previously held numerous leadership positions within its sales and supply chain functions. Resideo Leadership Team and Board of Directors
The Resideo leadership team will include the following individuals:
Thomas Surran, President and Chief Executive Officer. Mr. Surran has served as President of Resideo's Products and Solutions business since 2023. Joshua Foster, Senior Vice President, General Counsel and Corporate Secretary. Mr. Foster has served as Deputy General Counsel for Resideo since 2018 and previously spent over a decade at Honeywell in various capacities within the legal division. Scott Harkins, Senior Vice President of Sales and Marketing. Mr. Harkins has served as SVP of Resideo's Global Sales since 2020 and previously spent over 20 years with Honeywell, including as Vice President of Partner Development for Honeywell Connected Home. Amit Mehta, Senior Vice President of Strategy and Business Operations. Mr. Mehta has been with Resideo since 2019, and he will continue to lead strategy, corporate development and operational initiatives for Resideo. Patrick Murray, Senior Vice President of Integrated Supply Chain and Information Technology. Mr. Murray has been Resideo's Senior Vice President of Global Operations and Supply Chain since 2018. Ryan Strassburg, Senior Vice President and General Manager of Global Climate Solutions. Mr. Strassburg currently serves as Vice President and General Manager of Resideo's Global Climate Solutions business unit and previously held various leadership positions across Honeywell's sales, product management, and marketing teams. Scott Ziffra, Senior Vice President of Engineering. Mr. Ziffra has served as Resideo's SVP of Engineering and Product Management since 2020. Jeff Kutz, Senior Vice President and Chief Accounting Officer. Mr. Kutz will remain in his role as Resideo's Chief Accounting Officer. With the assistance of a leading search firm, the Resideo Board has an active search process underway to identify its new Chief Financial Officer.
Upon completion of the spin-off, the Resideo Board of Directors will comprise ten directors:
Cynthia Hostetler, Nathan Sleeper and Jay Geldmacher will resign from the Board. Andrew Campelli, a partner at CD&R, will be appointed to the Board. Andrew Teich will remain in his role as Chairman and all other current Resideo directors will continue as members of the Resideo Board. Mr. Geldmacher's retirement from Resideo will become effective upon completion of the separation, after which time, he will serve in an advisory capacity for six months. Thomas Surran will be appointed as a director, in addition to his role as President and Chief Executive Officer. Investor Days
Resideo and ADI will host separate investor days in mid-July in New York City. Members of the leadership teams will provide details on the businesses and outline their respective value creation strategies. Additional information, including dates, webcasts and registration, will be provided in the coming weeks.
Additional Information
Resideo expects the spin-off of ADI to be completed between mid-third quarter and mid-fourth quarter of 2026, subject to final approval from the Resideo Board and other customary conditions.
The planned spin-off of ADI is intended to be tax-free for Resideo and its stockholders for U.S. federal income tax purposes, except for cash that stockholders may receive (if any) in lieu of fractional shares. Consistent with the Form 10 process, the filing is an initial step in an iterative process and is subject to change. Additional information will be included in subsequent Form 10 filings. Future updates to the Form 10 will be filed with the SEC and may be viewed at www.sec.gov filings under ADI Global Distribution Inc.
ADI's common stock is expected to be listed on the New York Stock Exchange under the ticker symbol "ADIG".
About Resideo
Resideo is a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets. We are a leader in the home heating, ventilation, and air conditioning controls markets, smoke and carbon monoxide detection home safety and fire suppression products markets, and security products markets. Our solutions and services can be found in over 150 million residential and commercial spaces globally, with tens of millions of new devices sold annually. For more information about Resideo and our trusted, well-established brands including First Alert, Honeywell Home, BRK, Control4, and others, visit www.resideo.com.
Forward-Looking Statements
This press release contains forward-looking statements, including, but not limited to, those regarding the anticipated separation of Resideo Technologies' Products & Solutions and ADI Global Distribution businesses into two independent publicly traded companies, the expected timeline for completing the transaction, the strategic rationale and potential benefits of the separation, the anticipated financial and operational performance of each company following the separation, expected leadership transitions, future capital allocation priorities, growth initiatives, market positioning, and other future events or developments. Forward-looking statements are typically identified by such words as "anticipate," "believe," "could," "estimate," "expect," "intend," "may," "plan," "project," "should," "will," and similar expressions, although not all forward-looking statements contain these words. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially from those projected. Among the factors that could cause actual results to differ materially from those expressed or implied in any forward-looking statements are the possibility that the conditions to the separation may not be obtained or satisfied within the expected timeframe or at all; that the separation may not be completed on the anticipated terms or timing or may not occur at all; that the separation may not achieve the intended strategic, operational, or financial benefits for Resideo, its businesses, or its shareholders; that Resideo may experience operational or other disruptions as a result of the separation, including those relating to information technology systems, business processes, internal controls, customer and vendor relationships, and workforce alignment. Each separated company's ability to succeed as an independent enterprise will depend on numerous factors, including the execution of their respective strategies and plans, access to capital markets, the competitive landscape, and general business and economic conditions. Other risks and uncertainties include, but are not limited to, (1) our ability to achieve our outlook regarding the full year 2026, (2) our ability to recognize the expected savings from, and the timing and impact of, our existing and anticipated cost reduction actions, and our ability to optimize our portfolio and operational footprint, (3) the ability of Resideo to drive increased customer value and financial returns and enhance strategic and operational capabilities, (4) risks and uncertainties relating to tariffs that have been or may be imposed by the United States and other governments, and (5) the other risks described under the headings "Risk Factors" and "Cautionary Statement Concerning Forward-Looking Statements" in our Annual Report on Form 10-K for the year ended December 31, 2025 and other periodic reports as well as risks described under the heading "Risk Factors" of the Form 10 filed with the SEC.
All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks and uncertainties, which may cause the actual results or performance of the Company to differ materially from such forward-looking statements. Forward-looking statements are not guarantees of future performance, and actual results, developments, and business decisions may differ from those envisaged by our forward-looking statements. Except as required by law, we undertake no obligation to update such statements to reflect events or circumstances arising after the date of this press release and we caution investors not to place undue reliance on any such forward-looking statements.
Non-GAAP Financial Measures and Pro Forma Information
This press release includes certain "non-GAAP financial measures" as defined under the Securities Exchange Act of 1934 and in accordance with Regulation G thereunder, including Adjusted EBITDA and Adjusted EBITDA margin, as well as certain pro forma standalone financial information for ADI. Management believes the use of such non-GAAP financial measures assists investors in understanding the ongoing operating performance of the Company by presenting financial results between periods on a more comparable basis. Such non-GAAP financial measures should not be construed as an alternative to reported results determined in accordance with U.S. GAAP. Readers should also consider the limitations associated with these non-GAAP financial measures, including the potential lack of comparability of these measures from one company to another.
"Adjusted EBITDA" represents ADI's net income before interest expense, income tax expense (benefit), depreciation and amortization, adjusted to exclude the effects of unique and/or non-cash items that are not closely associated with ongoing operations, and provides management and investors with meaningful measures of our performance that increase the period-to-period comparability by highlighting the results from ongoing operations and the underlying profitability factors. "Adjusted EBITDA margin" is calculated as Adjusted EBITDA as a percentage of revenue.
The standalone financial information presented for ADI in this press release has been derived from the consolidated financial statements and accounting records of Resideo and reflects certain assumptions and allocations. The pro forma standalone financial information includes all revenues and costs directly attributable to ADI, as well as allocations of certain corporate expenses. These allocations may not be reflective of the actual expenses that ADI would have incurred as an independent, publicly traded company or of the costs it will incur in the future. For additional information regarding the basis of presentation, please see the Form 10 filed with the SEC.
The following table provides a reconciliation of net (loss) income and net (loss) income margin, the most closely comparable GAAP financial measures, to Adjusted EBITDA and Adjusted EBITDA margin:
ADI's Adjusted EBITDA and Adjusted EBITDA margin
2025
Net revenue
$
4,784
Net (loss) income
$
(261)
Net (loss) income margin
(5.5) %
Provision for income taxes
11
Income before taxes
(250)
Depreciation and amortization
115
Interest expense
50
Interest income
(8)
Indemnification Agreement expense (1)
364
Stock-based compensation expense (2)
24
Restructuring, impairment and extinguishment costs (3)
9
Transaction related expenses (4)
16
Other (5)
(2)
Adjusted EBITDA
$
318
Adjusted EBITDA margin
6.6 %
(1)
Consists of charges associated with the Indemnification Agreement that were allocated to the Combined Financial Statements. Refer to Note 10. Indemnification Agreement within the Combined Financial Statements for additional information.
(2)
Represents non-cash compensation expenses recognized for stock-based compensation arrangements.
(3)
Consists of non-recurring charges associated with restructuring initiatives as well as non-cash asset impairment charges and the allocation of debt extinguishment costs associated with third-party debt instruments.
(4)
Represents expenses incurred in 2025 for integration costs related to the Snap One Acquisition of $9 million and allocated transaction costs primarily related to third party vendors incurred due to the Spin-off of $7 million.
(5)
Represents amounts included in Other Expense reported on the Combined Statement of Operations.
Contacts:
Investors:
Christopher T. Lee
Global Head of Strategic Finance
[email protected]
Media:
Garrett Terry
Corporate Communications Manager
[email protected]
or
Dan Moore, Jim Golden, Tali Epstein
Collected Strategies
[email protected]
(1)
This press release includes certain "non-GAAP financial measures" as defined under the Securities Exchange Act of 1934. See reconciliations of U.S. GAAP results to adjusted results in the accompanying tables.
Net revenue of $1.91 billion, up 8% year-over-year and above the high-end of outlook range; P&S up 9% and ADI up 8% Total company gross margin of 28.8%; 12 consecutive quarters of year-over-year gross margin expansion achieved at P&S Net income of $38 million, compared to net income of $6 million in first quarter of 2025; Adjusted EBITDA(1) of $215 million, up 28% year-over-year and above the high-end of outlook range GAAP diluted EPS of $0.17; Adjusted EPS(1) of $0.65, up 3% year-over-year and above the high-end of outlook range , /PRNewswire/ -- Resideo Technologies, Inc. (NYSE: REZI), a leading global manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets, today announced preliminary financial results for the first quarter ended April 4, 2026.
First Quarter 2026 Financial Highlights
Net revenue of $1,912 million, up 8% compared to $1,770 million in first quarter 2025, and above the high-end of outlook range Total company gross margin of 28.8%, down 10 basis points year-over-year Net income of $38 million, compared to net income of $6 million in first quarter 2025 Adjusted EBITDA(1) of $215 million, up 28% compared to $168 million in first quarter 2025, and above the high-end of outlook range Diluted EPS of $0.17 and Adjusted EPS(1) of $0.65 compared to diluted loss per share of $0.02 and Adjusted EPS(1) of $0.63 in the first quarter 2025; first quarter 2026 Adjusted EPS(1) was above the high-end of outlook range Reported cash used by operating activities was $145 million compared to cash used by operating activities of $65 million in first quarter 2025 Management Remarks
"Our first quarter results reflect the continued strong operational execution of both businesses in a dynamic macro-economic environment, resulting in results that exceeded the high end of our outlook range for all financial metrics," said Jay Geldmacher, Resideo's President and CEO.
"I am very pleased with the focus, discipline, and leadership demonstrated by the P&S and ADI teams. The team's operational performance, along with the achievement of key business separation milestones, builds momentum and conviction for each company as we approach completion of the ADI spin-off later this year."
(1)
This press release includes certain "non-GAAP financial measures" as defined under the Securities Exchange Act of 1934. Resideo management believes the use of such non-GAAP financial measures, including Adjusted EBITDA, Adjusted Net Income, Adjusted EPS, and Adjusted Cash Provided by Operations, assists investors in understanding the ongoing operating performance of Resideo by presenting the financial results between periods on a more comparable basis. See reconciliations of U.S. GAAP results to adjusted results in the accompanying tables.
Products and Solutions First Quarter 2026 Highlights
Net revenue of $706 million, up 9% compared to 2025 Gross margin of 41.8%, up 40 basis points compared to 2025 Income from operations of $128 million, compared to $136 million in 2025 Adjusted EBITDA(1) of $177 million, or 25.1% of revenue, compared to $158 million, or 24.3% of revenue in 2025 P&S delivered net revenue of $706 million in the first quarter 2026, up 9% compared to first quarter 2025, including a favorable impact of approximately 200 basis points from foreign currency. Revenue grew year-over-year across substantially all our sales channels and product families. Revenue growth was driven by a combination of price realization, primarily in our OEM and security channels, and by customer demand for our new products, primarily in our retail and electrical distribution channels.
Gross margin was 41.8%, compared to 41.4% in first quarter 2025 due primarily to the continued achievement of structural operating efficiencies. Research and development expenses increased $9 million due primarily to investments supporting new product launches to drive future growth. Selling, general and administrative expenses were up $18 million driven primarily by a one-time litigation settlement. Restructuring expenses increased $7 million as we strategically optimize our global manufacturing footprint. Income from operations of $128 million in first quarter 2026 was down from $136 million in first quarter 2025 due primarily to the one-time litigation settlement and restructuring expenses. Adjusted EBITDA(1) grew 12% year-over-year to $177 million compared to $158 million in 2025.
ADI Global Distribution First Quarter 2026 Highlights
Net revenue of $1,206 million, up 8% compared to 2025 Gross margin of 21.2%, down 40 basis points compared to 2025 Income from operations of $34 million, compared to $34 million in 2025 Adjusted EBITDA(1) of $66 million, or 5.5% of revenue, compared to $72 million or 6.4% of revenue in 2025 ADI first quarter 2026 net revenue of $1,206 million was up 8% year-over-year, and reflects average daily sales growth of 1% year-over-year and four extra sales days in the current quarter. Both growth metrics include an approximate 1% favorable impact from foreign currency. Net revenue growth was driven by demand in the security, professional audio-visual, and data communications categories, partially offset by the residential audio-visual category due primarily to a continued soft U.S. residential market. E-commerce revenue grew 12% year-over-year, driven primarily by greater customer adoption. Exclusive Brands revenue also grew 7% year-over-year driven by positive momentum for our new products.
Gross margin was 21.2%, compared to 21.6% in first quarter 2025 due primarily to higher fuel costs for freight and unfavorable product sales mix. Research and development expenses increased $4 million due primarily to investments supporting new product launches that are intended to drive future growth. Selling, general and administrative were up $13 million driven primarily by higher variable costs during the four extra sales days. Income from operations of $34 million in first quarter 2026 was consistent with first quarter 2025 results. Adjusted EBITDA(1) decreased 8% to $66 million compared to $72 million in 2025.
Cash Flow and Liquidity
Net cash used by operating activities was $145 million in first quarter 2026, compared to cash used in operating activities of $65 million in first quarter 2025. The decrease was primarily driven by business separation activities, higher cash interest paid, and working capital dynamics. At April 4, 2026, Resideo had cash and cash equivalents of $438 million and total outstanding debt of $3.23 billion.
Outlook
The Company re-affirms its full year 2026 outlook and initiates its outlook for the second quarter 2026.
($ in millions, except per share data)
Q2 2026
2026
Net revenue
$1,916 - $1,940
$7,800 - $7,900
Non-GAAP Adjusted EBITDA(1)
$216 - $230
$935 - $985
Non-GAAP Adjusted Earnings Per Share(1)
$0.71 - $0.75
$3.00 - $3.20
Conference Call and Webcast Details
Resideo will hold a conference call with investors on May 12, 2026, at 5:00 p.m. ET. The webcast can be accessed at https://investor.resideo.com, where the webcast link and related materials will be posted before the call. A replay of the webcast will be available following the presentation.
About Resideo
Resideo is a leading manufacturer, developer, and distributor of technology-driven sensing and controls products and solutions for residential and commercial end-markets. We are a leader in the home heating, ventilation, and air conditioning controls markets, smoke and carbon monoxide detection home safety and fire suppression products markets, and security products markets. Our solutions and services can be found in over 150 million residential and commercial spaces globally, with tens of millions of new devices sold annually. For more information about Resideo and our trusted, well-established brands including First Alert, Honeywell Home, BRK, Control4, and others, visit www.resideo.com.
Contacts:
Investors:
Media:
Christopher T. Lee
Garrett Terry
Global Head of Strategic Finance
Corporate Communications Manager
[email protected]
[email protected]
Forward-Looking Statements
This release and the related conference call contain "forward-looking statements." All statements, other than statements of fact, that address activities, events or developments that we or our management intend, expect, project, believe or anticipate will or may occur in the future are forward-looking statements. Although we believe forward-looking statements are based upon reasonable assumptions, such statements involve known and unknown risks and uncertainties, which may cause the actual results or performance of the Company to differ materially from such forward-looking statements. Such risks and uncertainties include, but are not limited to, (1) our ability to achieve our outlook regarding the second quarter 2026 and full year 2026, (2) our ability to recognize the expected savings from, and the timing and impact of, our existing and anticipated cost reduction actions, and our ability to optimize our portfolio and operational footprint, (3) the amount of our obligations and nature of our contractual restrictions pursuant to, and disputes that have or may hereafter arise under the agreements we entered into with Honeywell in connection with the spin-off of Resideo from Honeywell, (4) the ability of Resideo to drive increased customer value and financial returns and enhance strategic and operational capabilities, (5) risks and uncertainties relating to tariffs that have been or may be imposed by the United States and other governments, (6) risks related to our anticipated separation of Resideo Technologies' Products & Solutions and ADI Global Distribution businesses into two independent publicly traded companies, including the timing thereof and that we may experience operational or other disruptions as a result of the separation and the planning therefor, and (7) the other risks described under the headings "Risk Factors" and "Cautionary Statement Concerning Forward-Looking Statements" in our Annual Report on Form 10-K for the year ended December 31, 2025 and other periodic filings we make from time to time with the Securities and Exchange Commission. Forward-looking statements are not guarantees of future performance, and actual results, developments, and business decisions may differ from those envisaged by our forward-looking statements. Except as required by law, we undertake no obligation to update such statements to reflect events or circumstances arising after the date of this press release and we caution investors not to place undue reliance on any such forward-looking statements.
Use of Non-GAAP Measures
This press release includes certain "non-GAAP financial measures" as defined under the Securities Exchange Act of 1934 and in accordance with Regulation G thereunder. Management believes the use of such non-GAAP financial measures assists investors in understanding the ongoing operating performance of the Company by presenting financial results between periods on a more comparable basis. Such non-GAAP financial measures should not be construed as an alternative to reported results determined in accordance with U.S. GAAP. Readers should also consider the limitations associated with these non-GAAP financial measures, including the potential lack of comparability of these measures from one company to another.
We have included reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and provided in accordance with U.S. GAAP at the end of this release. A reconciliation of the forecasted range for Adjusted EBITDA and Adjusted Earnings Per Share for the second quarter of 2026 and for the full year 2026 are not included in this release due to the number of variables in the projected range and because we are currently unable to quantify accurately without unreasonable efforts certain amounts that would be required to be included in the U.S. GAAP measure or the individual adjustments for such reconciliation. In addition, we believe such reconciliation would imply a degree of precision that would be confusing or misleading to investors. However, for the second quarter of 2026 and full year 2026 respectively, we anticipate the following expenses in our GAAP to non-GAAP reconciliation: depreciation and amortization of $53 million and $212 million, interest expense, net of $46 million and $181 million, and stock-based compensation expense of $14 million and $58 million.
Table 1: CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
Three Months Ended
(in millions, except per share data)
April 4, 2026
March 29, 2025
Net revenue
$ 1,912
$ 1,770
Cost of goods sold
1,361
1,259
Gross profit
551
511
Operating expenses:
Research and development expenses
48
35
Selling, general and administrative expenses
340
306
Intangible asset amortization
31
30
Restructuring expenses
6
4
Business separation costs
24
—
Total operating expenses
449
375
Income from operations
102
136
Indemnification Agreement expense (1)
—
90
Other expense (income), net
—
6
Interest expense, net
47
25
Net income before taxes
55
15
Provision for income taxes
17
9
Net income
38
6
Less: preferred stock dividends
9
9
Less: undistributed income allocated to preferred stockholders
3
—
Net income (loss) available to common stockholders
$ 26
$ (3)
Earnings (loss) per common share:
Basic
$ 0.17
$ (0.02)
Diluted
$ 0.17
$ (0.02)
Weighted average common shares outstanding:
Basic
151
148
Diluted
155
148
(1)
Represents the expense incurred pursuant to the Indemnification Agreement, which, prior to its termination, had an annual cash payment cap of $140 million. The following table summarizes information concerning the Indemnification Agreement:
Three Months Ended
(in millions)
April 4, 2026
March 29, 2025
Accrual for Indemnification Agreement liabilities deemed probable and reasonably
estimable
$ —
$ 90
Cash payments made to Honeywell prior to the third quarter of 2025
—
(35)
Indemnification Agreement non-GAAP adjustment
$ —
$ 55
Table 2: CONSOLIDATED BALANCE SHEETS (UNAUDITED)
(in millions, except par value)
April 4, 2026
December 31, 2025
ASSETS
Current assets:
Cash and cash equivalents
$ 438
$ 661
Accounts receivable, net
1,114
1,073
Inventories, net
1,357
1,354
Other current assets
265
270
Total current assets
3,174
3,358
Property, plant and equipment, net
444
447
Goodwill
3,096
3,100
Intangible assets, net
1,069
1,091
Other assets
424
437
Total assets
$ 8,207
$ 8,433
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable
$ 1,015
$ 1,131
Accrued liabilities
516
624
Total current liabilities
1,531
1,755
Long-term debt
3,165
3,167
Other liabilities
589
594
Total liabilities
5,285
5,516
Stockholders' equity:
Preferred stock, $0.001 par value: 100 shares authorized, 0.5 shares issued
and outstanding, and $500 liquidation preference at April 4, 2026 and
December 31, 2025
482
482
Common stock, $0.001 par value: 700 shares authorized, 160 and 151
shares issued and outstanding at April 4, 2026, respectively, and 158 and
150 shares issued and outstanding at December 31, 2025, respectively
—
—
Additional paid-in capital
2,410
2,391
Retained earnings
374
345
Accumulated other comprehensive loss
(168)
(157)
Treasury stock at cost
(176)
(144)
Total stockholders' equity
2,922
2,917
Total liabilities and stockholders' equity
$ 8,207
$ 8,433
Table 3: CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
Three Months Ended
(in millions)
April 4, 2026
March 29, 2025
Cash Flows From Operating Activities:
Net income
$ 38
$ 6
Adjustments to reconcile net income to net cash in operating activities:
Depreciation and amortization
51
47
Restructuring expenses
6
4
Stock-based compensation expense
14
15
Other, net
—
6
Changes in assets and liabilities:
Accounts receivable, net
(42)
(13)
Inventories, net
(6)
17
Other current assets
6
9
Accounts payable
(106)
(101)
Accrued liabilities
(114)
(112)
Non-current obligations payable under the Indemnification Agreement
—
54
Other, net
8
3
Net cash used in operating activities
(145)
(65)
Cash Flows From Investing Activities:
Capital expenditures
(36)
(31)
Net cash used in investing activities
(36)
(31)
Cash Flows From Financing Activities:
Repayments of long-term debt
(5)
—
Acquisition of treasury stock to cover stock award tax withholding
(32)
(15)
Preferred stock dividend payments
(9)
(9)
Other financing activities, net
4
2
Net cash used in financing activities
(42)
(22)
Effect of foreign exchange rate changes on cash, cash equivalents and restricted cash
1
3
Net decrease in cash, cash equivalents and restricted cash
(222)
(115)
Cash, cash equivalents and restricted cash at beginning of period
662
693
Cash, cash equivalents and restricted cash at end of period
$ 440
$ 578
Table 4: SUMMARY OF FINANCIAL RESULTS (UNAUDITED)
Q1 2026
(in millions)
Products
and
Solutions
ADI Global
Distribution
Corporate
Total
Company
Net revenue
$ 706
$ 1,206
$ —
$ 1,912
Cost of goods sold
411
950
—
1,361
Gross profit
295
256
—
551
Research and development expenses
36
12
—
48
Selling, general and administrative expenses
119
186
35
340
Intangible asset amortization
6
24
1
31
Restructuring expenses
6
—
—
6
Business separation costs
—
—
24
24
Income (loss) from operations
$ 128
$ 34
$ (60)
$ 102
Q1 2025
(in millions)
Products
and
Solutions
ADI Global
Distribution
Corporate
Total
Company
Net revenue
$ 649
$ 1,121
$ —
$ 1,770
Cost of goods sold
380
879
—
1,259
Gross profit
269
242
—
511
Research and development expenses
27
8
—
35
Selling, general and administrative expenses
101
173
32
306
Intangible asset amortization
6
23
1
30
Restructuring expenses
(1)
4
1
4
Income (loss) from operations
$ 136
$ 34
$ (34)
$ 136
Q1 2026 % change compared with prior period
Products
and
Solutions
ADI Global
Distribution
Corporate
Total
Company
Net revenue
9 %
8 %
N/A
8 %
Cost of goods sold
8 %
8 %
N/A
8 %
Gross profit
10 %
6 %
N/A
8 %
Research and development expenses
33 %
50 %
N/A
37 %
Selling, general and administrative expenses
18 %
8 %
9 %
11 %
Intangible asset amortization
— %
4 %
— %
3 %
Income (loss) from operations
(6) %
— %
76 %
(25) %
NON-GAAP FINANCIAL MEASURES AND RECONCILIATIONS
ADJUSTED DILUTED EARNINGS PER SHARE AND NET INCOME (LOSS) COMPARISON
(Unaudited)
RESIDEO TECHNOLOGIES, INC.
Three Months Ended
(in millions, except per share data)
April 4, 2026
March 29, 2025
GAAP Net income
$ 38
$ 6
Less: preferred stock dividends
9
9
Less: undistributed income allocated to preferred stockholders
3
—
GAAP Net income (loss) available to common stockholders
26
(3)
Indemnification Agreement non-GAAP adjustment (1)
—
55
Intangible asset amortization
31
30
Business separation costs
24
—
Litigation settlement
18
—
Stock-based compensation expense
14
15
Restructuring expenses
6
4
Undistributed income allocated to preferred stockholders
3
—
Other (2)
1
7
Tax effect of applicable non-GAAP adjustments (3)
(22)
(14)
Non-GAAP Adjusted net income
$ 101
$ 94
Three Months Ended
April 4, 2026
March 29, 2025
GAAP Net income (loss) available to common shareholders per diluted
common share
$ 0.17
$ (0.02)
Indemnification Agreement non-GAAP adjustment (1)
—
0.37
Intangible asset amortization
0.20
0.20
Business separation costs
0.15
—
Litigation settlement
0.12
—
Stock-based compensation expense
0.09
0.10
Restructuring expenses
0.04
0.03
Undistributed income allocated to preferred stockholders
0.02
—
Other (2)
—
0.05
Tax effect of applicable non-GAAP adjustments (3)
(0.14)
(0.10)
Non-GAAP Adjusted diluted earnings per share
$ 0.65
$ 0.63
(1)
Refer to the Unaudited Consolidated Statements of Operations herein.
(2)
Other includes net periodic pension benefit costs, excluding service costs, foreign exchange transaction loss (income), acquisition and miscellaneous other non-recurring, non-operating income and losses.
(3)
We calculate the tax effect of relevant non-GAAP adjustments by applying a flat statutory tax rate of 25% for all non-deductible and taxable adjustments.
NON-GAAP FINANCIAL MEASURES AND RECONCILIATIONS
ADJUSTED EBITDA AND NET INCOME COMPARISON
(Unaudited)
RESIDEO TECHNOLOGIES, INC.
Three Months Ended
(in millions)
April 4, 2026
March 29, 2025
Net revenue
$ 1,912
$ 1,770
GAAP Net income
$ 38
$ 6
GAAP Net income as a % of net revenue
2.0 %
0.3 %
Provision for income taxes
17
9
GAAP Net income before taxes
55
15
Indemnification Agreement non-GAAP adjustment (1)
—
55
Depreciation and amortization
51
47
Interest expense, net
47
25
Business separation costs
24
—
Litigation settlement
18
—
Stock-based compensation expense
14
15
Restructuring expenses
6
4
Other (2)
—
7
Non-GAAP Adjusted EBITDA
$ 215
$ 168
Non-GAAP Adjusted EBITDA as a % of net revenue
11.2 %
9.5 %
(1)
Refer to the Unaudited Consolidated Statements of Operations herein.
(2)
Other includes net periodic pension benefit costs, excluding service costs, foreign exchange transaction loss (income), acquisition and miscellaneous other non-recurring, non-operating income and losses.
NON-GAAP FINANCIAL MEASURES AND RECONCILIATIONS
(Unaudited)
PRODUCTS AND SOLUTIONS SEGMENT
Three Months Ended
(in millions)
April 4, 2026
March 29, 2025
Net revenue
$ 706
$ 649
GAAP Income from operations
$ 128
$ 136
GAAP Income from operations as a % of net revenue
18.1 %
21.0 %
Litigation settlement
18
—
Restructuring expenses
6
(1)
Stock-based compensation expense
5
5
Other (1)
$ (1)
$ (1)
Non-GAAP Adjusted Income from Operations
$ 156
$ 140
Depreciation and amortization
21
18
Non-GAAP Adjusted EBITDA
$ 177
$ 158
Non-GAAP Adjusted EBITDA as a % of net revenue
25.1 %
24.3 %
(1)
Other includes other miscellaneous adjustments.
ADI GLOBAL DISTRIBUTION SEGMENT
Three Months Ended
(in millions)
April 4, 2026
March 29, 2025
Net revenue
$ 1,206
$ 1,121
GAAP Income from operations
$ 34
$ 34
GAAP Income from operations as a % of net revenue
2.8 %
3.0 %
Stock-based compensation expense
4
4
Restructuring expense
—
4
Other (1)
(1)
2
Non-GAAP Adjusted Income from Operations
$ 37
$ 44
Depreciation and amortization
29
28
Non-GAAP Adjusted EBITDA
$ 66
$ 72
Non-GAAP Adjusted EBITDA as a % of net revenue
5.5 %
6.4 %
(1)
Other includes other miscellaneous adjustments and acquisition costs.
Resideo Technologies (REZI) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.61 per share. This compares to earnings of $0.63 per share a year ago.
Shares in residential and commercial sensing and controls company Resideo Technologies (REZI +2.73%) slumped by 15.5% by 11:30 a.m. today. The move comes due to the company's earnings report, and more pertinently, its second-quarter guidance and management's commentary on evolving market conditions.
Resideo Technologies disappoints the market Despite beating market expectations for the first quarter and reaffirming its 2026 outlook, the market focused on the lower-than-anticipated second quarter guidance and the pressures on profit margins coming from rising freight and fuel costs, and CEO Jay Geldmacher noting that "the high-end residential audio visual market has been softening."
Today's Change
(
2.73
%) $
0.85
Current Price
$
32.02
The margin pressures from fuel and freight costs aren't surprising in an environment where the ongoing closure of the Strait of Hormuz has sent oil prices gushing higher and impacted shipping costs due to diversions caused by the inability to ship through the Strait.
Given that backdrop, the last thing investors want to hear about is a softening in one of its higher-ticket price end markets.
Management intends to raise prices to offset cost increases, and it maintained full-year guidance for total net revenue of $7.8 billion to $7.9 billion and adjusted earnings per share (EPS) of $3 to $3.20. Still, the market stressed the guidance for second-quarter net revenue of $1.916 billion to $1.94 billion and adjusted EPS of $0.71 to $0.75, compared to Wall Street consensus expectations of $1.978 billion and $0.84, according to S&P Global Market Intelligence.
Image source: Getty Images.
Where next for Resideo Technologies Management believes the implementation of price increases will offset the cost increase. That remains to be seen, and the weakness in the high-end residential market is a watch item. Still, a swift resolution to the conflict and a successful price increase could put the stock back in favor.
Lee Samaha has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Resideo Technologies delivered Q1 revenue and adjusted EPS above expectations, reaffirming full-year guidance despite a 17.9% share price drop. REZI's upcoming spin-off of ADI Global Distribution is expected to unlock significant standalone value, with both segments positioned for improved operational focus. Valuation scenarios suggest REZI offers 28.1% to 187.2% upside, with current multiples already attractive relative to peers.